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CHAPTER I
INTRODUCTION AND REVIEW OF THE RELATED LITERATURE

CHAPTER I
INTRODUCTION AND REVIEW OF THE RELATED LITERATURE
A.

THE BIOSYNTHESIS OF HEME
All aerobic cells except the normal, mature, non-

nucleated erythrocyte synthesize heme, a quadridentate che. w1t
. h Fe+2
1ate comp 1 ex o f t h e tetrapyrro 1 e protoporp h yr1n
Numerous hemoproteins including hemoglobin, myoglobin, catalase, peroxidases, and cytochromes owe their activity, at
least in part, to heme.

Heme therefore functions as a pros-

thetic group for oxygen transport, plays an important role
in electron transport, and is involved in the detoxification
of a variety of xenobiotics.

The biosynthetic pathway lead-

ing to the formation of heme is the same regardless of its
site of synthesis or its ultimate function (FIGURE 1)
(Harris and Kellermeyer, 1970).
The synthesis of heme begins with the condensation of
the ubiquitous and readily available amino acid glycine and
the citric acid cycle intermediate succinyl CoA, with the
elimination of carbon dioxide, to form delta-aminolevulinic
acid (ALA).

This reaction is catalyzed by the mito-

chondrial enzyme delta-aminolevulinic acid synthetase
(ALAS), the only enzyme of heme synthesis requiring a cofactor (pyridoxal phosphate) and to which energy must be
2
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supplied (in the form of activated succinate) (Granick,
1958; Kikuchi et al., 1958).

The level of ALAS is the most

important rate limiting factor in the heme biosynthetic
pathway, being induced by certain sex hormones and drugs
(such as barbiturates) and being repressed by heme (Granick,
1966; Granick and Kappas, 1967; Kappas and Granick, 1968).
Heme also inhibits the activity of ALAS in a negative feedback fashion (Burnham and Lascelles, 1963; Karibian and
London, 1965).

Finally, the synthesis of ALAS can be in-

duced by erythropoietin with the subsequent appearance of
the other enzymes of heme synthesis (Nakao et al., 1968a).
The substituted monopyrrole precursor of all tetrapyrroles, porphobilinogen (PBG), was first isolated by
Westal (1952) from the urine of a porphyric human and characterized by Cookson and Rimington (1953).

Dresel and Falk

(1953) recognized the possibility that the aromatic compound PBG might be formed by the condensation of two molecules of the aliphatic compound ALA and postulated the existence of an enzyme catalyzing this reaction.

This soluble

cytoplasmic enzyme delta-aminolevulinic acid dehydratase
(ALAD; EC 4.2.1.24), which is present in all aerobic cells
including the normal, mature, non-nucleated erythrocyte, was
first isolated from ox liver by Gibson and co-workers (1955).
These investigators demonstrated that ALAD requires thiol
groups for activity and is inhibited in vitro by millimolar
concentrations of Pb +2 , Ag+ , Cu+2 , and Hg+2 , heavy metals

4

with a high affinity for sulfhydryl groups (Oehme, 1972).
They further demonstrated that ALAD is inhibited in vitro
by ethylenediaminetetraacetate (EDTA), a chelator of certain divalent metal ions (Martel and Calvin, 1952), strongly
suggesting involvement of metal ions in the enzymatic mechanism (Parisi and Vallee, 1969).

Heme has been reported to

inhibit ALAD in a negative feedback fashion (Calissano et
al., 1966).
In the succeeding step of heme synthesis four molecules of PBG condense, under the control of two cytoplasmic
enzymes, to form the tetrapyrrole ring compound uroporphyrinogen III.

These two enzymes are readily distinguished

on the basis of their susceptibility to heat inactivation.
PBG deaminase (PD), which is also called uroporphyrinogen
I synthetase, is quite heat stable (Bogorad and Granick,
1953) and catalyzes the removal of the amino group from PBG.
PD also catalyzes the head-to-tail condensation of four individual pyrroles into the symmetrical uroporphyrinogen I.
The second enzyme is uroporphyrinogen isomerase (UI) or uroporphyrinogen III cosynthetase and is quite unstable to
heat, being rapidly inactivated at 60°C (Bogorad and Granick,
1953).

UI will not, when free of PD, react with PBG or uro-

porphyrinogen I (Bogorad, 1958).

The exact mechanism of the

conversion of four molecules of PBG to uroporphyrinogen III
by the combined action of PD and UI remains unclear (Gidari
and Levere, 1977).

p

5

The four acetic acid side chains of uroporphyrinogen
III are enzymatically decarboxylated by the action of the
soluble cytoplasmic enzyme uroporphyrinogen decarboxylase
(UD) to produce coproporphyrinogen III (Mauzerall and
Granick, 1958).

This enzyme is active only on the fully

reduced porphyrinogen (Batlle and Grinstein, 1962).

UD de-

carboxylates the type III isomer at 7.5 times the rate of
the type I isomer when present in equal concentrations and
requires no cofactor (Cornford, 1964).
The conversion of coproporphyrinogen III to protoporphyrin IX is complex.

The propionate groups at positions

2 and 4 of coproporphyrinogen III are decarboxylated and
oxidized by the mitochondrial enzyme coproporphyrinogen
decarboxylase (CD) resulting in the formation of protoporphyrinogen IX (Granick and Mauzerall, 1958a).

This enzyme

has no activity toward the coproporphyrinogen I isomer and
requires no cofactor (Batlle et al., 1965).

Six hydrogens

are then enzymatically removed from protoporphyrinogen IX
to yield protoporphyrin IX but until recently it was uncertain whether the enzyme catalyzing this reaction is CD or
another enzyme (Sano and Granick, 1961).

In 1976 Poulson

demonstrated that there is indeed a second enzyme specific
for protoporphyrinogen IX, protoporphyrinogen IX oxidase
(POx) .
Heme is formed by the insertion of ferrous, but not
ferric, iron into the protoporphyrin IX ring in a reaction

p
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catalyzed by the enzyme heme synthetase (HS) or ferrochelatase (Hasegawa et al., 1970).

HS is a mitochondrial enzyme

(Jones and Jones, 1969) stimulated by reduced glutathione
and inhibited by lead (Goldberg et al., 1956).

In addition

HS is inducible and subject to end-product inhibition by
heme (Hasegawa et al., 1970).
There is a normal physiologic coordination between the
synthesis of heme and the synthesis of globin (Morell et al.,
1958).

It has been demonstrated that, in addition to in-

hibiting its own formation, heme enhances globin synthesis
(Bruns and London, 1965).

Furthermore, depletion of avail-

able heme results in a suppression of the biosynthesis of
globin (Heywood et al., 1972).

Thus the self-regulated

availability of heme provides the coordination between the
synthesis of heme and the synthesis of globin.

••
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B.

THE MOLECULAR PROPERTIES OF ALAD

1.

THE BASIC PROPERTIES OF ALAD
ALAD isolated from bacterial (Nandi et al., 1968; Van

Heyningen and Shemin, 1971; Nandi and Shemin, 1973), plant
(Tigier et al., 1970), and mammalian· (Doyle, 1971; Gurba et

-al.,

1972; Wilson et al., 1972; Cheh and Neilands, 1973; Wu

--

et al., 1974) sources and purified to varying degrees has
been described as having a molecular weight between 240,000
and 290,000.

The ALAD of Rhodopseudomonas spheroides (Van

Heyningen and Shemin, 1971) and mouse liver (Doyle, 1971)
is reported to be composed of six subunits and that from
bovine and rat liver of six or seven subunits (Gurba et·al.,
1972), each with a subunit molecular weight of 40,000.

Beef

liver ALAD was later reported to contain seven dimeric subunits with molecular weights of 35,500 (Wilson et al., 1972)
and seven or eight subunits with molecular weights of 36,000
(Cheh and Neilands, 1973).

Wu and associates (1974) found

bovine liver ALAD to be composed of eight similar subunits
with subunit molecular masses of 35,000; this is consistent
with its electron microscopic appearance as discrete lobes
arranged at the corners of a cube.

Shemin (1976) attributed

the discrepancies in the number of reported subunits to the
lack of sufficient material from the various sources rather
than to actual differences in the enzyme from the various
sources.

p
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It is well established that ALAD is inhibited in a
negative feedback fashion by heme (Burnham and Lascelles,
1963; Coleman, 1966; Calissano et al., 1966).

In addition,

the enzyme activity plotted as a function of substrate concentration and of cysteine concentration is sigmoidal (Nandi
et al.,
---

1968; Vergnano et al., 1968a).

--

These facts, to-

gether with the fact that the enzyme is composed of subunits, suggests that ALAD is an allosteric enzyme (Gerhardt
and Pardee, 1962; Martin, 1963; Monod et al., 1963).
ALAD from every source studied has been found to behave like a typical sulfhydryl enzyme (Shemin, 1972).
Wilson and fellow workers (1972) demonstrated the presence
of 56 cysteine residues per molecule of beef liver ALAD, approximately half of which are involved in inter- or intrasubunit disulfide linkages while the others, as determined
by titration with p-chloromercuribenzoate (Erwin and Pedersen, 1968), are free.

The report by Shemin (1976) of seven

cysteine residues per subunit is in complete agreement with
this while the report of Tsukamoto et al. (1975) of nine
cysteine residues per subunit is slightly at odds.

Both

authors report that two or three sulfhydryl groups are readily titrated with (5,5'-dithiobis(2-nitrobenzoic acid))
(Ellman, 1959) only after activation with exogenous thiols
or after denaturation of the enzyme, implying involvement in
disulfide linkage or existence in a buried position in the
enzyme.

In the presence of the competitive inhibitor

•
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levulinic acid only one sulfhydryl group can be titrated,
implying its presence at the active site and, possibly, the
formation of a thiohemiketal between it and the second, nonSchiff base bound ALA molecule.

One consequence of the

sulfhydryl nature of ALAD is that on purification the sulfhydryl groups become oxidized and the enzyme inactive; the
activity of the enzyme can be restored by the addition of
thiol activating reagents such as reduced glutathione
(GSH), dithiothreitol, and cysteine.

In addition, being

a sulfhydryl enzyme ALAD is susceptible to inhibition by
heavy metal ions which have a high affinity for sulfhydryl
groups (Oehme, 1972).
Crude preparations of mouse liver ALAD have been reported to be activated by the in vitro addition of EDTA
while EDTA has no effect on the purified enzyme (Coleman,
1966).

ALAD

from~-

spheroides

and~-

capsulata is similar-

ly unaffected by EDTA (Nandi and Shemin, 1973).

In vitro

EDTA, however, does inhibit ALAD from all other reported
bacterial (Yamasaki and Moriyama, 1971), fungal (Komai and
Neilands, 1969), yeast (DeBarreiro, 1967), plant (Nandi and
Waygood, 1967; Shetty and Miller, 1969; Tigier et al., 1970;
Schneider, 1970), and animal (Gurba et al., 1972; Wilson et
al., 1972; Yamada, 1972; Border et al., 1976a) sources,
strongly suggesting the involvement of divalent metal ions
in the mechanism of the ALAD from these sources (Parisi and
Vallee, 1969).

p
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2.

THE EFFECT OF METAL IONS ON ALAD ACTIVITY
It appears that ALAD, regardless of source, has the

same molecular mass, number of subunits, sulfhydryl character, metal ion requirement for maximal activity, and allosteric nature.

The exact nature of the effect of metal

ions, with the exception of lead (which will be discussed
further in other sections), on ALAD activity in vitro and
in vivo seems, however, to depend on the source of the enzyme and even then there is often disagreement.
Komai and Neilands (1968) found that ALAD activity in
crude extracts of the smut fungus Ustilago sphaerogena grown
in its sporoidal stage depends on the concentration of zn+ 2
in the culture media.

Enzyme activity is not lost on dialysis of the crude extracts and in vitro addition of zn+ 2 has
no effect on the enzyme up to 10- 4 M when it is inhibitory.
They, therefore, concluded that Zn+ 2 is necessary for the
synthesis of ALAD at the translation level but did not preclude the possible presence of a firmly bound essential
.
metal ion s~nce
Zn+2 , Fe +2 , and, to a lesser extent, Cd+2
enhance the activity of the purified enzyme as well as that
treated with chelating agents.

In a subsequent paper (1969)

they reported that Cu+ chelating agents are powerful inhibitors of the enzyme and there is a moderately good correlation between the activity of ALAD from U. sphaerogena and
its copper content after purification.

The ligand-treated
enzyme from U. sphaerogena cannot be reconstituted by Cu+ 2
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because it is a potent inhibitor but it can be reactivated
by zn+Z which is isoelectronic with Cu+.
ALAD from the yeast Saccharomyces cervisiae is also
inhibited by millimolar concentrations of Cu+ 2 as well as by
Hg+ 2 while Mg+ 2 is added to the enzyme preparation without
effect (DeBarreiro, 1967).

Divalent magnesium at a concen-

tration of 3.3 mM is, however, necessary for the maximum activity of the ALAD from Mycobacterium phlei. At a concentration 0.33 mM, Mg+2 can reverse the EDTA-induced inhibition of the enzyme from this source (Yamasaki and Moriyama,
1971).
ALAD from the photosynthetic bacteria R. spheroides
and

~·

capsulata is the only ALAD unaffected by EDTA.

A

purified and well-dialyzed preparation of ALAD from R. capsulata is active without the addition of any cation but millimolar concentrations of either Fe+ 2 or Fe+ 3 inhibit the
enzyme (Nandi and Shemin, 1973).

The enzyme

from~·

spher-

oides requires K+ or a related ion such as Li+, Rb+, NH +,
4
2
.
.
.
or Mg+ f or act~vat~on
at 1 ow sub strate concentrat~ons
(Nandi et al., 1968).

In the presence of these ions the en-

zyme associates into a mixture of monomer, dimer, and trimer
(Nandi and Shemin, 1968a).
Wheat leaf ALAD is completely inhibited by millimolar
concentrations of Cu+ 2 and Hg+ 2 while the same concentration
of Na+, K+, Fe+ 2 , Co+ 2 , Ni+2 , Zn+ 2 , and Pb+ 2 is without effect on the enzyme. A 10- 4 M concentration of Mg+ 2 , Ca+ 2 ,
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or Mn+ 2 can activate wheat leaf ALAD, the activation by
Mn+ 2 being able to overcome inhibition by EDTA in a stoichiometric fashion (Nandi and Waygood, 1967).

Tobacco leaf ALAD
is inhibited by low concentrations of both Fe+ 2 and EDTA; low
concentrations of both Mg+ 2 and Mn+ 2 partially reverse the

inhibition of ALAD by EDTA but at higher concentrations only
Mg+ 2 is an activator (Shetty and Miller, 1969). It has been
reported by Schneider (1970) that ALAD from spinach leaves
is inactive after dialysis and application of EDTA but is
reactivated by Mg+2 and, to a lesser degree, Mn+2 low concentrations of ca +2 ' Fe +2 , and Zn+ 2 inhibit the enzyme from
this source but Na+, K+, and NH + are without effect. In
4
contrast to this, Tigier et al. (1970) reported the maximum
activity of ALAD from the soybean callus is observed when it
is grown is a culture medium containing 10- 6 M Zn+ 2 and concluded Zn+ 2 is essential for enzyme synthesis.
The divalent cations Mg+ 2 , Ca+ 2 , Ba+2 , Mn+ 2 , Fe+ 2 , and
Zn+ 2 have no effect on mouse liver ALAD while Cu+ 2 and Pb+ 2
inhibit the enzyme at low concentrations. ALAD from this
source is moderately activated by Fe+ 2 at 10- 3 M and more
markedly activated by Hg+ 2 at 10- 4 to 10- 3 M which can also
prevent the inhibition of ALAD by 10-S M Cu+ 2 (Coleman,
1966).
Tomio and co-investigators (1968) found that neither
purified ALAD nor the crude preparation from the rat Harderian gland requires the addition of any metal ion for maximal
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activity.

However, Cu+2 , Hg+2

Ag+ , and Pb +2 , each at a fi-

nal concentration of 0.1 to 1.0 mM, inhibit the enzyme.
While millimolar concentrations of MgC1 2 have a moderate inhibitory effect on the enzyme, when Mg+ 2 is added as the
sulfate it activates the enzyme as do the sulfate salts of
NH + and K+.
4
Rat erythrocyte ALAD has been reported to be activated
to 250% of control activity by 2 mM Al+ 3 , to 240% of control
activity by 0.18 mM Zn+ 2 , and to 360% of control activity by
the combination of the two (Meredith et al., 1974).

Mere-

dith and associates also report that aluminum sulfate activates rat liver ALAD in vivo.

Zinc also affects erythro-

cytic ALAD in vivo for its activity is markedly decreased
when the rats are fed a low zinc diet. The in vitro addition of Zn+ 2 to hemolysates of zn+ 2 deficient rats results
in only a slight increase in ALAD activity, suggesting zn+ 2
is required at the level of ALAD synthesis (Finelli et al.,
1974; Finelli et al., 1975).
In an early report of the metal content of ALAD purified from beef liver, Iodice et al. (1958) found 0.1% copper
in the enzyme with magnesium being the only other metal present.

Gurba and associates (1972), on the other hand, re-

ported the hepatic ALAD to contain approximately 1 g-atom
of zinc per 270,000 g of protein as well as smaller, nonstoichiometric amounts of iron and cobalt.
According to Cheh and Neilands (1973) the ALAD from
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bovine liver contains 1.2 g-atoms of zinc per mole of enzyme
and possesses only 25% of the activity ultimately observed
after titration with between 5 and 6 g-atoms of Zn+ 2 per
mole.

This represents the upper limit of the Zn+

2

require-

ment because kinetic and competitive factors diminish the
effectiveness of added metal hence only half of the 7 or 8
subunits of the enzyme must be involved in Zn+ 2 binding.
These investigators also reported that Cd+2 restores full
activity to the purified enzyme but Mg+ 2 , Ca+ 2 , Cr+ 3 , Fe+ 2 ,
Fe+ 3 , Ni+ 2 , Cu+, and Cu+ 2 are inactive. Shemin (1976) similarly found, by determining the number of atoms of Zn+ 2
per mole of enzyme necessary to restore full activity to
the bovine apo-enzyme, that the enzyme contains 4 to 6 atoms
of zinc per molecule of enzyme. It was further discovered
. .
. ~ne
. ff ect~ve
.
.
.
.
o f z n+ 2 ~s
~n restor~ng act~vt h at t h e a dd ~t~on
ity to the purified enzyme unless it is first reduced by a
reduced thiol.
The activity of beef liver ALAD inhibited by 10 ~M
EDTA can be completely restored by 100 ~M Zn+ 2 which is
considered by Wilson et al. (1972) to be an absolute requirement for the enzyme. In addition, they reported that
1 mM zn+ 2 is a competitive inhibitor of ALAD, 100 ~M Mg+ 2 ,
Ca+ 2 , Fe+ 2 , and Cu+ 2 have no effect on the enzyme, and 100
~

.
M Cd+ 2 ~s

.

un~que

.

~n

th at at 1 ow sub s t ra t e

.

concentrat~ons

it inhibits ALAD while at higher substrate concentrations
it activates the enzyme.

In a rather unusual study Ramp
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and Kriebitzsch (1975) found that both 500 ~M Zn+2 and 100
~M Cd+ 2 enhance the activity of bovine erythrocytic ALAD
when stored with the enzyme for two to six weeks at -30°C.
The effect of various metal ions on purified human
erythrocytic ALAD,was investigated by Ca1issano et al.
(1965) who found K+, Mg+ 2 , Ca+ 2 , and Fe+ 3 to be without effect on the enzyme while Mn+ 2 and Co+ 2 are weak and Pb+ 2 ,
Ag+ , Cu+2 , and Hg+2 are powerful inhibitors of the enzyme.
2
On the other hand, Fe+ stimulates ALAD at all concentrations from 5 x 10- 6 M to 5 x 10- 3 M and zn+ 2 stimulates
ALAD at all concentrations between 5 x 10- 5 M and 5 x 10- 4
M while inhibiting it at 5 x 10- 3 M. According to Collier
(1971) a fresh hemolysate dialyzed against a solution of
EDTA has only 10% of the activity of an undialyzed preparation and its activity can only be restored by Mn+ 2
Milli. h"b"t
.
mo 1 ar concentrat~ons
o f Fe + 2 an d Co+ 2 ~n
~ ~
t h e un d"~a 1yz.
e d enzyme, Ca +2 h as no e ff ect on ~t,
an d Mn+ 2

.

act~vates

.

~t.

Abdulla and Haeger-Aronsen (1971) incubated various
concentrations of Zn+ 2 with a human whole blood hemolysate
for four hours and found that 4.6 X 10- 5 M zn+ 2 inhibits
ALAD slightly while 7.6 x 10 - 4 Man d 1.5 x lo- 3 M zn+ 2
stimulate the enzyme to 172 and 201% of the control activity, respectively.

These investigators also reported the
oral administration of 30 to 40 mg of zn+ 2 (as the sulfate)
per day for four weeks in one volunteer resulted in a suecessive increase in erythrocytic ALAD activity but they

jP
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presented no actual data for this.
The effects of Mg+ 2 , Ca+ 2 , Mn+ 2 , Co+ 2 , Ni+ 2 , Zn+ 2 ,
Cd+ 2 , and Hg+ 2 at concentrations ranging from 10- 7 M to
10- 2 M on the ALAD activity of human whole blood hemolysates was investigated by Mitchell and associates (1977).
They discovered that both Cd+ 2 and Hg+ 2 stimulate ALAD at
10- 5 M before inhibiting it at higher concentrations, zn+ 2
stimulates the enzyme maximally at 10- 4 M but at no concentration is it inhibitory, and the other ions are without
+2 can protect ALAD against
effect. They also found that Zn
inhibition by EDTA down to 10-l M EDTA and that the stimulation of the enzyme by Zn+ 2 is additive with that by sulfhydryl reagents, implying different mechanisms of stimulation.
The inhibition or ALAD by the in vitro addition of
EDTA is well established but its in vivo effect has only
recently been studied.

At a plasma EDTA concentration of

0.2 to 0.4 mM a 5% decrease in the erythrocytic ALAD activity and a 14% decrease in the hepatic ALAD activity of the
normal rat is observed while at the same plasma concentrations in vivo lead-induced inhibition of hepatic ALAD is
almost completely reversed (Hammond, 1973).

These effects

of EDTA on ALAD in vivo apparently also occur in man.

In

lead-intoxicated children treated with Na 2 (Ca-EDTA) there is
a transient increase in serum and urinary ALA concentrations
(possibly reflecting a further inhibition of the enzyme by
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EDTA) followed by a rapid and pronounced fall in both serum
and urinary ALA concentrations (reflecting removal of the
lead from, hence reactivation of, ALAD) (Chisolm, 1968a).
Trisodium calcium diethylenetriaminepentaacetate,
Na (ca-DTPA), the most effective and widely used chelation
3
agent for reducing actinide contamination in man, has an
ability to remove zinc that is approximately 100 times more
than that of Na 2 (ca-EDTA) (Catsch et al., 1968). In baboons treated with Na 3 (Ca-DTPA), whenever the concentration
of Zn+Z in the catheterized urine was greater than approximately four times the normal value erythrocytic ALAD activity was decreased to less than one-half of the normal value (Cohen and Guilmette, 1976).

In patients with cirrho-

sis a similar effect is observed for in these patients a
40% decrease in plasma zinc concentrations and a 48% decrease in erythrocytic ALAD activity has been observed.
The fact that the activity of ALAD in patients with cirrhosis is less enhanced by the in vitro addition of Zn+Z than
it is in lead intoxicated patients led these investigators
to conclude there is a decreased synthesis of ALAD as a result of the decrease in zn+Z (Allain et al., 1977).
Copper deficiency may not have the same effect on
erythrocytic ALAD activity zinc deficiency has.

In a single

patient receiving intravenous feedings containing insufficient copper, a copper deficiency anemia resulted but the
erythrocytic ALAD activity was normal.

This is consistent
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with the observation of the same researchers that the erythrocytic ALAD activity in rats fed a copper deficient diet
containing adequate levels of zinc is normal (Finelli et
al., 1974).

This, however, is in marked contrast to the

observation that hepatic ALAD activity in rats and erythrocytic ALAD activity in ducklings is decreased 30 to 50% if
dietary copper is missing (Iodice et al., 1958).
There are three heavy metals that are generally recognized as being ubiquitous environmental contaminants:
lead, mercury, and cadmium (Vallee and Ulmer, 1972).

The

in vivo effect of each of these on human erythrocytic ALAD
activity has been investigated.

Wada et al. (1969) found

a moderate decrease in the ALAD activity of workers occupationally exposed to mercury below the old threshold limit
value (TLV) of 0.1 mg/m 3 whose urinary mercury exceeded
200

~g/gm

creatinine; neither ALAD activity nor urinary

mercury levels, however, correlated with the erythrocyte
glutathione levels or the urinary ALA excretion, which were
normal in all cases.

Among workers exposed to mercury

vapor below the new TLV of 0.05 mg/m 3 and at the exposure
level of the general population there is no decrease in
erythrocytic

AL~D

activity or increase in urinary ALA

(Lauwerys and Buchet, 1973).

This same group of

i~vesti-

gators also found that occupational exposure to cadmium has
no effect on ALAD activity, urinary ALA excretion, or red
cell glutathione levels (Lauwerys et al., 1973; Reels et

19
1975). Thus of the three metals generally recognized
-al.,
as environmental contaminants only lead causes a significant
in

~

inhibition of erythrocytic ALAD.

It

.

~s

.

.

~nterest~ng

to note t h at

sn +2

which has the

same electronic configuration as Pb+ 2 , inhibits erythrocytic ALAD activity when administered intraveneously to rabbits but Sn+ 4 does not (Chiba and Kikuchi, 1978).
Thus, while there is no universal agreement with respect to the metal ion requirement of ALAD, there does appear to be nearly unanimous agreement that the enzyme loses
activity on purification.

This appears to be due to the

tendency of ALAD to lose its metal ion on purification or
to the oxidation of its many sulfhydryl groups on purification or to both.
While there is no agreement about the metal ion requirement of ALAD it is, nonetheless, tempting to speculate
that:

the enzyme from anaerobic microbial sources which

synthesize the cobalt-containing porphyrin vitamin B12
Cu + , Zn + 2 , or Mg+ 2 ; t h at f rom p h otosynt h et~c
. m~cro.
.
requ~res
organisms which synthesize the manganese-containing porphyrin chlorophyll requires Ca+2 Mg+2 , or Mn+2 ; ALAD from
eukaryotic microorganisms and mammalian sources which synthesize the iron-containing porphyrin heme require Cu+ ,
zn+ 2 , or Fe+ 2 . However, while on the basis of the current
evidence there is considerable overlap of metal ion requirements for ALAD but no consensus, the generalizations with

20
respect to the metal ion requirement of ALAD based on the
ultimate destination of the porphyrin moiety appears unjustified.

Clearly, further work is necessary to clarify the

exact nature of the metal ion requirement of ALAD from the
various sources.

3.

THE MECHANISM OF PORPHOBILINOGEN SYNTHESIS
A Schiff base is an imine resulting from the conden-

sation of an amine and a carbonyl-containing compound such
as an aldehyde or a ketone (Snell and DiMari, 1970):

+
amine

)

aldehyde or ketone

imine

Incubation of an enzyme with the substrate in the presence
of sodium borohydride (NaBH 4 ) with the consequent loss of
enzymatic activity confirms the formation of a Schiff base
between the carbonyl group of the substrate and the epsilonamino group of a lysyl residue of the enzyme.

Concomitant

with the loss of enzymatic activity is a stoichiometric
binding of radioactive substrate to the enzyme (Horecker
et al., 1963; Grazi et al., 1963).
ALAD from

g.

spheroides (Nandi and Shemin, 1968b; Van

Heyningen and Shemin, 1971), R. capsulata (Nandi and Shemin,
1973), mouse liver (Doyle, 1971) and bovine and rat liver
(Gurba et al., 1972) is almost completely inactivated by
NaBH 4 in the presence of 14 c ALA with radioactivity bound
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to the enzyme in a stoichiometric ratio.

The formation of

a Schiff base by one molecule of ALA with ALAD precludes
the initial formation of a Schiff base between the two substrate molecules.

Furthermore, the formation of a Schiff

base between ALA and ALAD results in a stabilized carbanion
which can make a nucleophilic attack onto the carbonyl carbon of a second molecule of ALA resulting in an aldol condensation.

There is then an enzyme catalyzed elimination of

water between the carbon atom bearing the newly formed hydroxyl group and the adjacent carbon atom.

In the final

step the amino group of the ALA molecule not in Schiff base
linkage with the enzyme makes a nucleophilic attack on the
highly reactive carbon atom in Schiff base linkage with the
enzyme resulting in the formation of a gem diamine.

The

amino group of the enzyme then leaves the gem diamine and
the conjugated pyrrole PBG, which is no longer able to react with the enzyme, is formed.

The formation of PBG in

this manner (i.e. transamination) serves two purposes; it
is a trap driving the reaction to completion and it provides a mechanism for freeing the product from the active
site of the enzyme (Nandi and Shemin, 1968b).
In an extension of this mechanism Cheh and Neilands
(1974) proposed the participation of divalent zinc in a
Lewis acid polarization of the carbonyl group of the second
molecule of ALA, facilitating the nucleophilic attack of
the first, Schiff base-bound, substrate molecule.
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The observation that only four of the eight subunits
of ALAD form a Schiff base with ALA indicates the enzyme
exhibits the phenomenon of negative cooperativity and halfsite reactivity (Shemin, 1976).

That is, the maximal stoi-

chiometric yield of an enzyme-'-substrate covalent intermediate or product in a single turnover is equal to half
the number of apparently equivalent active sites.

This is

a consequence of the peculiar quaternary structure of the
native enzyme or the native enzyme-substrate intermediate
resulting in the absence of a twofold axis of symmetry in
the oligomeric state (Seydoux et al., 1974).
Batlle and co-workers (1978) investigated the dissociation, reassociation, and rehybridization of bovine liver
ALAD attached to Sepharose.

They found that each catalytic

site of the enzyme could function independently of the
other within-a dimeric formation.

They, therefore, postu-

lated (Batlle and Stella, 1978) that the minimum structure
necessary for enzymatic activity is a dimer having one subunit involved in the formation of a Schiff base with one
molecule of ALA while the second subunit binds noncovalently
with the second molecule of ALA, holding it in place.

The

histidine residue present in each of the active sites
(Tsukamoto et al., 1975) are, in this model, assigned the
role of transferring protons to and from the active center
of the basic mechanism described above.

The two subunits

are held together, according to this model, at intersubunit
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contact sites by ionic, covalent, coordinate covalent,
or hydrogen bonds in which the sulfhydryl groups of the enzyme as well as the metal activator (e.g. divalent zinc)
participate.
The half site reactivity of a functional dimer catalyzing this rather rare reaction in which two identical substrate molecules participate would help explain the early
observation of Granick and Mauzerall (1958b) that the affinity of ALAD for the first molecule of ALA is at least ten
times greater than its affinity for the second.

The first

molecule binds covalently to one subunit while the second
molecule binds noncovalently to the second subunit.

4.

THE ACTIVATION OF LEAD-INHIBITED ALAD BY THIOLS, METAL
IONS, pH CHANGE, AND HEATING
Lead inhibits ALAD from all mammalian sources in

vivo and in vitro in a noncompetitive fashion (Wilson et
al., 1972; Sassa et al., 1975).

The inhibition of ALAD

can, nonetheless, be reversed both in vitro and in vivo.
The in vivo and in vitro inhibition of erythrocytic
ALAD caused by lead can be reversed by the in vitro addition
of thiol compounds including reduced glutathione (Lichtman
and Feldman, 1963), cysteine (Bonsignore et al., 1965), and
dithiothreitol (Granick et al., 1973).

The reactivation of

the lead inhibited ALAD by thiols is considered to be the
result of a thiol-mercaptide exchange between the added
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thiol and the lead-sulfhydryl complex of the lead inhibited
enzyme.

Hapke and Prigge (1973) attributed the difference

in thiol activated ALAD between a lead contaminated group
and a control group to a normalization of the free part of
the enzyme by a resynthesis of the enzyme.
Granick and fellow investigators (1973) found an excellent correlation between blood lead levels and the ratio
of thiol activated ALAD activity to nonactivated ALAD activity.

The linearity of this ratio, which eliminates the

broad distribution of ALAD activities due to genetic variation (Sassa et al., 1975), down to unity at a blood lead
level of 15

~g

per 100 ml of whole blood led these workers

to conclude that this is the threshold for the effect of
lead on ALAD.

Below this concentration they assume lead

binds to some group (perhaps on the erythrocyte membrane)
with a higher affinity for lead than ALAD.
These results have led some to hypothesize that the
endogenous concentration of GSH in erythrocytes plays a
regulatory role in the activity of ALAD (Moore et al., 1971)
and that this control mechanism might be affected by lead
(DeBarreiro, 1969).

Indeed, there is a well established

moderate but significant decrease in the endogenous erythrocyte GSH concentration in lead intoxicated workers (Shiraishi, 1952; Rubino et al., 1963; Batolska and Marinova,
1970).

Furthermore, one group reports that the in vivo ad-

ministration of GSH to lead intoxicated workers improved
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the decreased ALAD to some extent (Nakao et .al., 1968b).
Abdulla and Haeger-Aronsen (1973) observed that relatively high concentrations of zinc could antagonize the
heavy metal-induced inhibition of erythrocytic ALAD in
vitro.

Finelli and fellow workers (1975) have reported the

reversal of the in vivo and in vitro lead-induced inhibition of erythrocytic ALAD by the in vitro addition of divalent zinc.

These authors also noted a protective effect of

zinc on the inhibitory effect of lead during in vivo studies
on rats.

They suggested the in vivo stimulation of lead

inhibited ALAD by zinc can be a useful tool for the diagnosis of lead intoxication.

Their conclusion, on the basis

of these results, was that zinc is functioning at the active
site of ALAD, possibly at sulfhydryl groups, to displace
lead and thereby reactivate the enzyme.
In 1976 Haust and associates reported the case of a 7
year old lead poisoned girl with pica who had inadvertently
ingested approximately 5 g of zinc oxide.

These workers

noted a tenfold increase in erythrocytic ALAD activity on
day 5 after the ingestion and another, less dramatic, rise
on day 13 after the ingestion of zinc and another on day 17.
These increases in erythrocytic ALAD activity were related
to increases in red cell zinc provided there was no concomitant increase in red cell lead or copper.
Aluminum has been reported to activate in vitro lead
inhibited erythrocytic ALAD in vitro and hepatic ALAD

p
26
activity in vivo (Meredith et al., 1974).

These observa-

tions, however, should be viewed with caution since these
authors used a 0.5 M potassium phosphate buffer which
might interfere with the results (Finelli et al., 1974).
Mitchell et al. (1977) used an assay incorporating
both divalent zinc and a thiol compound, GSH, with incubation with the substrate at 50°C for 10 to 20 minutes.

The

extent of activation of normal erythrocytic ALAD by zinc
and by GSH was found to be similar but the combined effects
were additive, suggesting these two agents activate ALAD by
different mechanisms.

The natural logarithm of the ratio

of activated e.rythrocytic ALAD activity to nonactivated
erythrocytic ALAD activity was found to be directly proportional to the blood lead concentration with the correlation between these two values being higher than that reported by Granick and co-workers (1973) for their GSH activated
system as reported above.
Nikkanen and associates (1972) have demonstrated that
the optimum pH for erythrocytic ALAD determination is lower
in persons occupationally exposed to lead than in normal
individuals.

Using this observation, Tomokuni (1974) found

the rate of decrease of the ratio of erythrocytic ALAD activity determined at pH 6.8 to that determined at pH 6.0 to
be proportional to the increase of the blood lead level.
From these results Tomokuni concluded that lead regulates
ALAD activity from an allosteric site on the molecule which
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changes in conformation as the pH is lowered, thereby preventing lead from interfering with the active site of the
enzyme.
ALAD is remarkably heat stable, being capable of
withstanding temperatures as high as 60°C for at least 20
minutes without significant loss of activity (Coleman, 1966;
Nandi et al., 1968; Wilson et al., 1972).

The reaction

rate increases nearly linearly with increasing temperature
up to 60°C with the reaction rate at 50°C being nearly
three times that at 37°C (Mitchell et al., 1977).

The

thermal stability of ALAD can be exploited to determine
whether or not ALAD is a regulatory enzyme because mild
heating is classically employed to make such enzymes insensitive to metabolite inhibition at allosteric sites (Gerhardt and Pardee, 1962; Martin, 1963; Monod et al., 1963).
Several groups of investigators have used the technique of heating the whole blood hemolysate at 60°C for
5 minutes prior to incubation with substrate in order to
determine the mechanism by which lead inhibits ALAD with
mixed success and contradictory conclusions (Bonsignore et
al., 1968; Vergnano et al., 1968b; Tomokuni and Kawanishi,
1975; Chiba, 1976).

There was complete agreement that the

heat treatment reversed the inhibitory effect of lead on
erythrocytic ALAD if the inhibition was due to chronic in
vivo exposure to lead.

There was similar agreement that

the heat treatment potentiated lead-induced inhibition if
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lead was added to a hemolysate of normal blood prior to preincubation and weakened the inhibitory action of lead if it
was added to a normal blood hemolysate after preincubation.
On the other hand, the ALAD activity of a liver homogenate
was actually decreased by the heat treatment (Coleman, 1966;
Vergnano et al., 1968b).

These results led Vergnano et al.

(1968b) and Tomokuni and Kawanishi (1975) to conclude that
lead causes an allosteric modification of the active site
resulting in enzymatic inhibition.

Bonsignore et al.,

(1968) concluded, on the basis of the same results, that
the lead-induced inhibition of ALAD is due to the action of
a thermolabile allosteric effector or to a structural modification at the level of synthesis of the enzyme or to the
variation in the level of a phantom normal isoenzyme.
Chiba (1976) hypothesizes the existence of two components
of erythrocytic ALAD:

type 1, inherently active without

heat treatment, is inhibited by lead in a mannner that cannot be restored by heat treatment; type 2, inherently inactive without heat treatment and relatively insensitive to
lead, may be inactivated by higher concentrations of lead.
The explanation offered by Chiba appears to be the most
reasonable especially if one imagines the type 2 ALAD to be
that fraction of all ALAD inhibited in a negative feedback
fashion by heme (Calissano et al., 1966), the level of
which could be increased in chronic lead intoxication as a
result of hemolysis (Hernberg et al., 1967; Berk et al.,
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1970).

Indeed both the degree of hemolysis (Hernberg et

al., 1967) and the ratio of heat treated erythrocytic ALAD
activity to unheated erythrocytic ALAD activity (Tomokuni
and Kawanishi, 1975; Chiba, 1976) are directly proportional
to the blood lead level.
The basic conclusion derived from the reactivation of
lead-inhibited erythrocytic ALAD by thiols, metal ions, pH
change, and heating is that lead inhibits the enzymatic
activity directly and does not inhibit the synthesis of the
enzyme.

What is still open to question is whether this in-

hibition is at the active site or at an allosteric site.
In addition, the assessment of erythrocytic ALAD
activity with and without activation of the enzyme by
thiols, metal ions, pH change, or heating and the calculation of the simple ratio of activated to nonactivated ALAD
activity has several advantages over the use of the nonactivated ALAD assay in the assessment of lead intoxication.
These advantages have been summarized by Mitchell and asso.ciates (1977) and include:
a.

the ratio increases with an increase in the blood
lead level and is more closely correlated with it
than is the erythrocytic ALAD activity alone

b.

the units of enzyme activity need not be computed
thus avoiding the confusion of the many different
methods of expressing the erythrocytic ALAD activity

c.

the results do not need to be normalized by use of
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the hemoglobin concentration or the hematocrit
d.

the broad range of enzymatic activity resulting
from genetic differences in erythrocytic ALAD
activity is eliminated as a source of error

e.

activation of the enzyme provides a positive
internal control of the test.
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c.

THE ACTIVITY OF ALAD IN DISEASE STATES

1.

THE ACTIVITY OF ALAD IN CERTAIN

M~EMIAS

The components of the heme biosynthetic pathway in the
erythrocyte are sensitive to changes in red cell turnover
and red cell age in both health and disease as well as to a
variety of genetic, developmental, and environmental factors
(Harris and Kellermeyer, 1970) and ALAD is no exception.
For example, human erythrocytic ALAD is inherited in a codominant fashion resulting in a broad range of enzymatic
activity (Sassa et al., 1973a).

As additional examples,

repeated phlebotomy (Abdulla et al., 1975), phenylhydrazineinduced (i.e. hemolytic) anemia (Abdulla and Svensson, 1978),
and iron deficiency anemia (Sharma, 1973) in rats stimulate
erythropoiesis and a subsequent increase in ALAD activity
which can be correlated with a greater number of circulating
reticulocytes.

It is, therefore, not surprising that

changes in erythrocytic ALAD activity in a variety of human
anemias, both before and after the initiation of therapy,
have been reported.

These reports, however, have not always

been in agreement.
A hemolytic disease exists in any situation in which
the in vivo life span of the erythrocyte is shorter than
normal.

The hemolytic process is considered to be compen-

sated if the rate of red cell destruction is such that an
increase in erythrocyte production can compensate for the
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excessive destruction.

A compensated hemolytic process is

generally reflected by a partial shift of reticulocytes from
the bone marrow to the peripheral blood.

In severe, albeit

at least partially compensated, hemolytic anemias due to
hemoglobinopathies (including SS, SC, and S-S-thalassemia)
and other, miscellaneous, causes (e.g. autoimmune hemolytic
anemia) as well as in compensated mild hemolysis (e.g. Bthalassemia trait) ALAD activity is significantly increased.
In addition, the increase in erythrocytic ALAD activity in
these hemolytic diseases is clearly associated with an increase in the number of reticulocytes (Rubino et al., 1960;
Feldman and Lichtman, 1964; Anderson et al., 1977).
The megaloblastic anemias are due to varying degrees
of abnormality in the metabolism of vitamin B12 or folic
acid or both together. The result of this abnormal metabolism is ineffective erythropoiesis producing, if untreated,
an uncompensated macrocytic, hypochromic anemia.

In the

megaloblastic anemias due to vitamin B12 or folic acid
deficiencies erythrocytic ALAD activity is reported to be
both decreased (Rubino et al., 1960) and increased with no
substantial difference in technique hence no ready explanation for the discrepency in the results (Battistini et al.,
1971).

Both authors, however, agree that the activity of

erythrocytic ALAD increases with the reticulocyte response
during the response to the appropriate therapy.
Iron lack or deficiency anemia is an uncompensated
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hypochromic microcytic anemia due to depletion of the iron
normally available to meet metabolic requirements.

In iron

deficiency anemia erythrocytic ALAD activity has been reported to be unchanged (Rubino et al., 1960; Lichtman and
Feldman, 1963; Prato et al., 1968; Gutniak et al., 1971;
Battistini et al., 1971) and increased (Heilmeyer, 1964;
Kaneko, 1970; Mazza et al., 1971; Chalevelakis et al., 1977).
The explanation of this difference is suggested by the observation of Sharma (1973) that the enzyme activity in iron
deficient rats was unchanged when expressed as units/ml of
blood but was increased when more properly expressed as
units/ml of packed red cells.

There is, nonetheless, agree-

ment that the activity of erythrocytic ALAD increases with
the reticulocyte response during therapy (Rubino et al.,
1960; Mazza et al., 1971).
The association of an increase in erythrocytic ALAD
activity with the reticulocytosis of hemolytic anemia as
well as with that associated with the response of vitamin
B12 , folic acid, and iron deficiency anemias to appropriate
therapy has an important implication. A decrease in the
components of the heme biosynthetic pathway with red cell
ageing is anticipated because hemoglobin synthesis is active
in bone marrow erythroid cells and reticulocytes but not in
circulating mature erythrocytes that have lost their cellular organelles.

These observations suggest that with the

maturation of the erythrocyte, in addition to the loss of
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mitochondrial heme biosynthetic enzymes, there is a more
gradual decline in the activity of the soluble cytoplasmic
enzyme ALAD.

The decline in enzymatic activity could re-

flect a degradation of enzyme protein or another mechanism
such as the loss of a cofactor or the progressive increase
in the concentration of an inhibitor.

To evaluate the mech-

anism of the decline in ALAD activity with an increase in
the age of the erythrocyte population it might be important
to have an experimental model in which there is little
genetic variation in enzymatic activity but varying degrees
of a naturally occurring reticulocytosis.

2.

AN ANIMAL MODEL FOR STUDYING THE ASSOCIATION OF ERYTHROCYTIC ALAD ACTIVITY viTTH RETICULOCYTOSIS
The neonatal and developing rat is a potentially use-

ful model for studying the relationship between erythrocytic
ALAD activity and the degree of reticulocytosis.

A macro-

cytic hypochromic anemia is characteristic of the early
neonatal

peri~d

of the rat.

This anemia appears to be a

partially compensated hemolytic anemia in light of the
erythroid hyperplasia, the increased rate of macrocyte
disappearance, and the increased degree of reticulocytosis
(ranging from 89% at day 1 to 29% at day 10 and 3.7% at day
40) that has been observed (Lucarelli et al., 1964).

These

unique features had initially suggested that erythropoietic
activity in the neonatal rat is governed by a mechanism
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different than that of the adult (Lucarelli et al., 1968).
It has, however, subsequently been demonstrated that
erythropoiesis in the neonatal rat is indeed regulated by
the same hypoxia-erythropoietin mechanism present in the
adult (Matoth and Zaizov, 1970; Zaizov and Matoth, 1970).
The unique hematologic picture presented by the newborn and
developing rat is a reflection of the transition from
hepatic to bone marrow erythropoiesis, a transition similar
in many ways to that observed during the last trimester of
normal human gestation (Michels, 1931).
A preliminary observation that adult rats weighing
200 g or more had approximately one-half of the erythrocytic
ALAD activity of younger animals weighing 100 g or less
(Finelli et al., 1974) suggests that there may indeed be a
correlation between erythrocytic ALAD activity and reticulocyte percent in the developing rat.

If that were indeed the

case, the developing rat could provide a useful model for
investigating the mechanism of the decline of erythrocytic
ALAD activity with an increase in the age of the cell.

In

addition, it could serve to demonstrate an important source
of variability in lead poisoning analysis in newborn and
developing rats.

3.

THE ACTIVITY OF ALAD IN LEAD POISONING ANEMIA
The important hematologic finding in lead poisoning is

anemia which is perhaps the best understood effect of lead
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in man.

A decrease in the blood hemoglobin concentration

begins to appear at relatively low levels of lead exposure;
the ultimate anemia can be constant and severe in children
(Watson et al., 1958) but is generally mild in the adult
(Rubino et al., 1959; Griggs, 1964; Waldron, 1966) except
at very high levels of exposure when a frank anemia is
observed (Williams, 1966).

The threshold of blood lead

exposure for the appearance of anemia appears to be a blood
lead level of 40

~g/100

ml in children (Pueschel et al.,

1972; Betts et al., 1973) and 50
et al., 1973).

~g/100

ml in adults (Tola

The anemia is typically normocytic and

slightly hypochromic (Fullerton, 1952) and the reticulocyte
percent is usually elevated to the 2 to 7% range.

The mild

anemia found in most patients with lead poisoning appears
to be the result of several different effects of lead.
Lead has a direct, hemolytic action on the erythrocyte
resulting in a moderate shortening of the erythrocyte survival time that can be correlated with anemia, reticulocytosis,
and blood lead levels (Hernberg et al., 1967).

These

authors found the erythrocyte destruction to be nonrandom,
indicating lead shortens the true life span of the erythrocyte, but others found a random shortening of the red cell
life span (Berk et al., 1970).

The shortening of the red

cell life span is of such a degree that the bone marrow
should be able to adequately compensate and hemoglobin
depression should not be observed.

That hemoglobin
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depression is observed suggests that lead also inhibits the
production of erythrocytes by the bone marrow.
There is indeed direct evidence for lead inhibition of
both heme and globin biosynthesis.

In acute lead poisoning

the synthesis of globin has been demonstrated to be markedly
disturbed although the investigators were unable to determine whether or not this was primarily due to lead acting at
some level in globin synthesis (White and Harvey, 1972).

It

was subsequently demonstrated that the abnormality in the
synthesis of globin seen in lead poisoning occurs only
secondarily to a deficit in the production of heme (Piddington and White, 1974).

The deficit in heme production is the

consequence of the inhibition of the two heme biosynthetic
enzymes that are sensitive to lead.
Gibson and Goldberg (1970) measured heme synthetase .
activity of brain, liver, kidney, and bone marrow in rats
exposed subacutely to parenteral lead and found no inhibition by lead.

They did, however, find that the addition of

lead acetate in concentrations similar to those present in
the original unhomogenized tissues, 10- 4 H, produced marked
inhibition of HS.

A direct consequence of HS inhibition in

vivo is an increase in the concentration of protoporphyrin
IX in the blood (generally referred to as free erthrocytic
protoporphyrin-FEP-or zinc protoporphyrin-ZnP) which is
directly proportional to the blood lead levels in patients
without iron deficiency (Granick et al., 1972; Chisolm et
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al., 1974; Piomelli, 1977). Since the erythrocyte has no
-mitochondria,
an increase in FEP reflects bone marrow lead
effects and chronic lead poisoning (Sassa et al., 1973b).
ALAD is the other heme biosynthetic enzyme for which
there is substantial evidence of lead-induced inhibition.
Ever since Bonsignore et al. (1965) unequivocally established that erythrocytic ALAD is markedly inhibited in both
acute and chronic lead poisoning, it has repeatedly been
demonstrated that the activity of erythrocytic ALAD is inversely proportional to the blood lead level.

This in vivo

dose-response relationship has been demonstrated in frank
as well as in sub-clinical lead poisoning (DeBruin, 1968;
Nakao et al. , 1968b; Hernberg et al. , 1970; Haeger-Aronsen
et al., 1971; Weissberg et al., 1971; Hcintire et al.,
1973) and in the normal urban population as a result of
environmental lead pollution (Hernberg and Nikkanen, 1970;
Secchi et al., 1971).
The threshold level for the inhibition of ALAD by lead
is 15

~g

of lead per 100 ml of whole blood (Granick et al.,

1973) and this effect is linear to a level of 120
per 100 ml of whole blood (Roels et al., 1974).

~g

of lead

The obser-

vation of most investigators that ALAD that is 90% inhibited
in vivo or in vitro by relatively high concentrations of
lead cannot be further inhibited by lead was confirmed by
Goldstein and associates (1975) in baboons administered lead
intravenously or orally for nearly six months.

The failure
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to demonstrate a continued decrease in ALAD activity after

90% inhibition by lead led Weissberg and fellmv workers
(1971) to conclude that this is the limit of the sensitivity
of the assay.

However, this may actually represent a

natural biochemical process since the -SH groups of ALAD are
protected from oxidation in the presence of the substrate
ALA (Granick et al., 1973) which may increase in lead
poisoning to such a level that it protects that enzyme not
yet inhibited by lead.

Alternatively, the normal endogenous

levels of GSH or some metal activator of ALAD may be high
enough to prevent or reverse the lead-induced inhibition of
10% of erythrocytic ALAD.
Aside from providing an extremely sensitive measure of
the degree of lead exposure, the inhibition of erythrocytic
ALAD is of questionable significance since the erythrocyte
lacks the mitochondrial enzymes participating in heme synthesis.

However, inhibition of erythrocytic ALAD is prob-

ably a reflection of the inhibition of the enzyme in the
erythroid precursors of the bone marrow.

In addition, a

correlation between erythrocytic ALAD activity and the
activity of liver ALAD in man (Secchi et al., 1974) and
between erythrocytic ALAD activity and the activity of liver
and brain ALAD in lead poisoned suckling rats (Millar et al.,
1970) has been demonstrated.

The consequences of this are

as yet undetermined but potentially highly significant.
One known and well established consequence of the
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inhibition of ALAD by lead is the marked increase in the
urinary excretion of ALA.

Urinary ALA excretion rises above

normal limits in an exponential fashion in both adults
(Haeger-Aronsen, 1960; Selander and Cramer, 1970) and children (Davis et al., 1968).

Raised urinary ALA concentra-

tions are closely correlated with plasma levels that are
elevated prior to the urinary increase (Haeger-Aronsen, 1960;
Chisolm, 1968b).

The source of this increased urinary and

plasma ALA was suggested by Gibson and Goldberg (1970) who
showed that, in rabbits treated with chronic parenteral lead
acetate, liver, kidney, and bone marrow ALA increases to
levels 2, 12, and 100 times the control levels, respectively
The blood lead threshold for the elevation of plasma and
urinary ALA is approximately 45

~g

of lead per 100 ml of

whole blood, which is appreciably higher than that for ALAD
inhibition, suggesting the body has a considerable functional ALAD reserve (Lauwerys et al., 1974).

4.

THE POSSIBLE CONSEQUENCES OF ALA ACCUMULATION
Acute intermittent porphyria (AIP) is a genetically

controlled disease of a chronic nature; the genetic defect
involves the overproduction of ALA in the liver as a result
of the induction of ALAS (Marver and Schmid, 1972) and a
decreased metabolism of ALA to heme due to a partial lack of
PD activity (Meyer et al., 1972) resulting in an increased
excretion of ALA and PBG.

One consequence of the elevated
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hepatic ALA biosynthesis and decreased ALA metabolism is an
increase in the plasma and cerebrospinal fluid concentrations of ALA (Sweeney et al., 1970).

~fuen

ALA reaches the

serum equilibrium levels seen in AIP it has been demonstrated to pass into various organs of the body including the
heart and gut (McGillion et al., 1975).

In addition, as

suggested by the increase in the cerebrospinal fluid concentration of ALA, the elevated plasma concentration can pass
the blood-brain barrier and enter the brain tissue (Kramer
et al., 1971; McGillion et al., 1974); Becker et al. (1974),
using rabbit brain cortical slices, actually demonstrated
brain uptake of ALA via an active transport-like system.
Thus in both AIP and lead poisoning there is an increase in
tissue and plasma ALA concentrations as well as an increased
urinary excretion of ALA.
The signs and symptoms of 50 cases of lead poisoning
have been compared with those of 50 cases of patients suffering from AIP and striking similarities have been observed (Dagg et al., 1965).

The porphyria triad of abdominal

pain, constipation, and vomiting was found to be the most
common symptom complex of lead poisoning.

The incidence

and distribution of non-abdominal pain were nearly identical.
In addition, neuropsychiatric manifestations, paresis or
paralysis, paresthesias, and cardiovascular abnormalities
(including tachycardia and hypertension) were observed in
both diseases but the incidence and severity were generally
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greater in AIP.

Finally, there is a notable similarity of

the pathologic changes affecting the nervous system in both
diseases which includes a segmental demyelination of the
peripheral nerves.
Purified porphyrins and PBG have been demonstrated to
be pharmacologically inactive (Goldberg et al., 1954) as has
ALA (Jarrett et al., 1956).

Nonetheless, the clinical and

pathologic similarities between AIP and lead poisoning suggest, despite different etiologies of the diseases, arelated pathogenesis.

The possibility that the common feature

of these diseases, the increased levels of ALA, may be the
underlying cause of the clinical and pathologic similarities
is, therefore, being reinvestigated.

The possible direct

toxic effect of ALA in the pathogenesis of an acute attack
of AIP (hence, possibly, in lead poisoning) is further
implied by the recent observation (Dhar et al., 1975) of a
clinical remission and the return to normal of elevated
plasma ALA levels after infusion of hematin which, it will
be recalled, inhibits ALAS.
In studying the pathogenesis of the hypertension and
tachycardia seen in AIP several investigators have found a
significant correlation between both blood pressure and
pulse rate and the amount of urinary catecholamines excreted (Schley et al., 1970; Atuk et al., 1975).

The etiology

of the increased excretion of catecholamines was, until
recently, unclear.

In 1977 Beal and associates demonstrated
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a significantly reduced platelet uptake and accumulation of
norepinephrine (NE) in the presence of both 1 and 10

~M

ALA in patients with AIP but no similar reduction in the
platelets of normal patients.

The AIP patients' platelets

were by no means deficient in uptake capacity since their
control uptake of NE was actually greater than that of
platelets from normal controls and NE uptake could be significantly decreased in both patients with AIP and normal
patients by desmethylimipramine.

Both the significantly

greater control platelet uptake of NE and the significantly
decreased platelet uptake of NE in the presence of ALA led
these investigators to conclude that there is a latent
defect in catecholamine uptake or accumulation in the platelets of patients with AIP which becomes apparent only in the
presence of ALA.

Since platelet uptake serves as a model of

adrenergic neuronal uptake (Abrams and Solomon, 1969; Born
and Smith, 1970) and reuptake is the principle means of
terminating the physiologic action of NE in vivo (Molino££
and Axelrod, 1971), the elevated circulating catecholamines
observed during acute attacks of AIP could be caused, at
least in part, by blocked reuptake of catecholamines into
adrenergic neurons (Beal et al., 1977).

It would be inter-

esting to look for a similar latent defect in those lead
intoxicated individuals with hypertension and tachycardia.
Isoniazid produces a pattern of denervation in rats
that is similar to that observed in AIP (Cavanagh, 1967) .
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The principle toxic action of isoniazid is the depletion of
pyridoxal phosphate by increasing the excretion of pyridoxal
(Holtz and Palm, 1964).

It is likely that the neurologic

lesion is a result of tissue deprivation of this cofactor
since it can be reversed or prevented by pyridoxal phosphate
(Zbinden and Studer, 1955).

The similar patterns of denerva-

tion led Cavanagh and Ridley (1967) to postulate a similar
etiology in AIP.

That is, the excessive activity of the

pyridoxal phosphate-requiring enzyme ALAS leads to a relative tissue depletion of pyridoxal phosphate and the
observed neurologic lesion.

However, no correlation between

plasma pyridoxal phosphate levels and neuropathy was
observed in patients with AIP and those with low pyridoxal
phosphate levels did not improve after the administration
of the vitamin (Hamfelt and Wetterberg, 1968).

Thus, while

a relative pyridoxal phosphate deficiency might have explained the denervation and, because of decreased levels of gammaamino-butyric acid (GABA) (due to the inhibition of the
pyridoxal phosphate-dependent enzyme of GABA synthesis,
glutamic acid decarboxylase) (Roberts, 1963), the other
neurologic features of AIP, factors other than this must be
responsible.
The structural similarity of ALA and GABA, a ubiquitous inhibitory transmitter in the central nervous system
(Johnston, 1978), suggests that ALA might interact with GABA
receptors.

Nicoll (1976) studied the perfused frog spinal
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cord using the sucrose gap technique and found that ALA,
added to the preparation in a Ringer solution at pH 7.3,
activates GABA receptors on motoneurons, hyperpolarizing
them, and on primary afferent fibers, reducing transmitter
release from them in response to incoming volleys.

The

threshold concentration for the effect of ALA reported by
Nicoll is 2 to 5 x 10- 5 H while that for the effect of GABA
II
is 10 -5 M. Muller and Snyder (1977) found that concentrations of ALA causing postsynaptic and presynaptic inhibition
in the frog spinal cord preparation compete with GABA for
crude synaptic membrane Na+-independent GABA receptor binding on frog and rat spinal cords as well as on rat brain
synaptosomes.

Both studies demonstrated the relative

potencies of GABA and ALA are more alike in their effect on
postsynaptic than on presynaptic inhibition.

In addition,

Becker et al. (1976) showed that ALA causes an increased
release of GABA from both stimulated (at 0.5 11H) and nonstimulated (at 100 11H) rabbit cerebral cortex synaptosomes.
Muscimol, a potent GABA-mimicking drug, causes ataxia,
muscle weakness, slowing of thought processes, dysphoria,
and occasional psychotomimetic effects with hallucinations
(Theobald et al., 1968), symptoms reminiscent of the muscle
weakness and psychiatric symptoms observed in AIP and lead
poisoning (Goldberg, 1959; Roth, 1968).

It is therefore

possible that some of the symptoms of AIP and lead poisoning
may be the result of the effect of ALA on GABA receptors as
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well as on GABA release.
A direct presynaptic inhibitory effect of 0.6 to 18 mM
ALA at the cholinergic synapse of the rat neuromyal junction was demonstrated in 1979 by Bornstein and fellow workers.

Thus, ALA causes a decrease in the number of quanta of

acetylcholine (ACh) released by a nerve impulse but has no
effect on the depolarization produced by a single quantum of
ACh or on the postsynaptic resting membrane potential.
Becker and co-workers (1971) showed that 10- 4 to 2 x
a Na + , K+ -act~vate
·
d a d·enos~ne
·
· h os~l ALA .;nh.;b.;ts
~
~ ~
tr~p
10 - 3 ~""
phatase (Na,K-ATPase) in rabbit erythrocyte and brain membranes.

This enzyme helps to maintain the Na+ and K+

gradient across the cell membrane and inhibition by ALA
would cause the membrane to become leaky with a resulting
decrease in resting membrane potential and a possible block
of nerve conduction.

More recently Becker and associates

(1975), using electrophysiologic techniques, demonstrated
that ALA can produce a relatively rapid and large decrease
in the resting membrane potential of a single fiper from
the sartorius muscle of the frog in a reversible and dose
dependent manner over a concentration range of 10 -4 to
10 - 3 M.

This decrease is not likely to be mediated sole 1y

by an inhibition of the Na,K-ATPase· but probably also
involves an alteration in membrane permeability to Na+ and
K+ by unknown mechanisms possibly involving the release of a
depolarizing substance.
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The in vitro effects described above occur, for the
most part, at a concentration (10- 4 M) at least ten times
higher than that typically found in the plasma of patients
with lead poisoning and acute attacks of AIP (10- 6 to 10- 5
M) .

This has caused some to question whether circulating

ALA is toxic and led to the speculation of another endogenous or induced defect of heme synthesis within the nervous
system that is responsible for the symptoms of AIP and lead
poisoning (Shanley et al., 1976; Shanley et al., 1977).
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D.

THE PHYSICAL AND CHEMICAL PROPERTIES OF METAL IONS

1.

THE ELECTRON CONFIGURATION (Weidner and Sells, 1968;
Cotton and Wilkinson, 1972)
An atom of an element of atomic number Z consists of a

small, dense nucleus composed of neutral particles, neutrons,
and Z positively charged particles, protons, embedded in a
cloud of Z considerably smaller and less massive negatively
charged particles, electrons.

While the electron cloud is

highly dynamic, the arrangement of electrons around the nucleus of an element can be described in terms of occupation
of orbitals within successive energy levels.

This is re-

ferred to as the electron configuration of an element.

The

physical and chemical properties of an element are largely
dependent on its electron configuration and elements with
similar electron configurations have similar properties.
Electrons of an atom occupy successive principal energy
levels designated by

~

and of positive integral values with

the values of n equal to 1, 2, 3, 4, 5, and 6 corresponding
to the K, L, M, N, 0, and P shells, respectively.

Principal

energy levels are divided into sublevels designated by
which has integral values from 0 to

(~-1)

l

with the values

1 equal to 0, 1, 2, and 3 corresponding to the ~· £• d,
and f sublevels, respectively. The ~. £, ~. and f sub-

of

levels have (21 + 1) orbitals, each of equal energy but
each with a different spatial orientation in the presence
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of an external magnetic field.

These spatial orientations

are designated by the orbital magnetic,
intergral

values~.

1-1, ... ,

0, ... ,

~l'

which has the

1-l, -1.

Each orbital

can have a maximum of two electrons with parallel and opwith a value of
p osite' spin magnetics, designated m,
-s
either +% or -%.
Although the principal energy levels represent the
general order of magnitude of the energy of an electron, the
least stable sublevels of one principal energy level may be
of higher energy than the most stable sublevels of the next
higher level hence will fill after them.

Furthermore, ac-

cording to Hund's Rule orbitals of one sublevel accommodate
single electrons of parallel spins in each before the
pairing of electrons in the orbitals in that sublevel begins.
The numbers £,
bers.

~.

~ ,

1

and

~s

are known as quantum num-

According to the Pauli Exclusion Principle no two

electrons of an atom have the same set of quantum numbers;
this is the basis of the structure of the Periodic Table.
When the unique set of quantum numbers for each and every
electron in an atom is known, the electron configuration of
the atom is established.

According to the famous Pauli

Aufbauprinzip, the different orbitals, each with its unique
set of quantum numbers, are arranged in order of increasing
energy
5~.

(1~,

2~,

2£,

3~,

3£,

4~,

3~,

4~,

5~,

4~,

5£,

6~,

4f,

6£) and the electrons placed into the orbital of lowest
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energy until all Z electrons have been accommodated.

The

periodicity of electron configurations is a result of the
recurrent filling of successive principal energy levels; the
periodicity of chemical properties reflects the periodicity
of the electronic configurations.

Each column of the Perio-

dic Table contains elements with similar electron configurations hence similar chemical properties.
Certain electron configurations are more stable than
others.

The electron configurations of the noble gases,

which have two s electrons and six £ electrons in their outer shells, are especially stable.

Configurations in which

subshells are either filled or half filled are also quite
stable.

It is the tendency of atoms to acquire either

closed shell electron configurations of noble gases or
filled or half filled subshells through the sharing of
electrons with other atoms (covalent bond formation) or
through electron transfer (the formation of ionic bonds)
that accounts for their oxidation states.
Each electron orbital is a well defined region in
space in which the electrons of that orbital are most
likely to be found.

As mentioned above, each orbital has a

different spatial orientation.

If one imagines the atomic

nucleus to be situated at the origin of three mutually perpendicular Cartesian axes (x, y, and z) it is possible to
describe the spatial orientation of the orbitals of the
three subshells usually involved in the formation of
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chemi·cal bonds.

The single s orbital is spherically sym-

metrical with respect to the origin.

The three £ orbitals

have dumbbell shapes with each orbital oriented along one of
the three axes and with the node of the dumbbells at the origin.

Four of the d orbitals have cloverleaf shapes; three

are oriented in the xy, xz, and yz planes with their lobes
situated between the axes and their nodes at the origin
while the fourth has its lobes along the x and y axes with
its node at the origin.

The final d orbital has a dumbbell

shape with a torus wrapped around the center; the dumbbell
is oriented along the z axis with its node at the origin and
the torus is in the xy plane.

The set of orbitals of each

sublevel are spherically symmetrical with respect to the
nucleus.

It is the fact that a symmetrical arrangement of

electrons about the nucleus is energetically favorable that
accounts for the stability of filled or half-filled subshells.

2.

THE COORDINATE BOND (Basolo and Johnson, 1964; Basolo
and Pearson, 1967)
A coordination compound contains one or more coordi-

nate covalent bonds which are covalent bonds in which one of
the two atoms involved supplies both of the electrons of the
bond.

The electron pair acceptor of the coordinate covalent

bond is the central ion and is, typically, an ion of a metal
with d orbitals.

The coordinating groups, or ligands, are

,.
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ions or neutral molecules which are the electron pair donors
in the formation of the coordinate covalent bond.

The

number of coordinate covalent bonds that can exist betwen
the central ion and the ligands is the coordination number
of the ion.
Alfred Werner laid the foundation of modern structural
inorganic chemistry when, in 1893, he proposed his coordination theory.

The central principle of this theory, for

which Werner won the 1913 Nobel Prize in Chemistry (Werner,
1966), is that most elements have two types of valence, a
primary valence corresponding to its oxidation state and a
secondary valence corresponding to its coordination number.
According to Sidgewick (1927) a central ion, having achieved
a stable, non-noble gas electron configuration through
oxidation will often surround itself with enough ligands
that the tot'al number of electrons around the metal is the
same as that in a noble gas.

This concept is often useful

in predicting the coordination number of a central metal
ion.
There are three theories that are used to explain the
properties of coordination compounds.

These three (the

valence bond theory, the electrostatic theory, and the molecular orbital theory) differ in the manner in which they
consider the approach of ligands to affect the central atom
and its orbitals.

However, all three theories qualitatively

account for the main features of coordination complexes.
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Therefore, the theory that is the most convenient in the
present application, the valence bond theory, will be
discussed.
Linus Pauling was awarded the 1954 Nobel Prize in
Chemistry for developing his theory of chemical bonding
(Pauling, 1966).

According to his valence bond theory

(Pauling, 1960) the number of orbitals on the central ion
made available for the formation of coordinate covalent
bonds with orbitals on the ligands must equal the number of
ligands.

Since the strongest coordinate covalent bond is

the result of maximum angular overlap of the two coordinating orbitals, the coordinating atomic orbitals of the
central metal atom must form hybrid orbitals, all of which
are equivalent and have definite spatial arrangements.

The

geometry of the coordination complexes is established by the
geometry of the hybrid orbitals.

Thus, for example, if the

coordination number is 2, 4, or 6 and the coordinating
orbitals are one s and one£, one s and three
one~·

and two £ 1 S, or two d's,

one~·

£

1

S,

one d,

and three £'S then

the respective geometry of the coordinating orbitals and the
resultant coordination compounds is linear

(~

hybridiza-

tion), tetrahedral (~3 hybridization), square planar
(dsp 2 hybridization) or octahedral Ci2 sp 3 hybridization).
A cr bond is a coordinate covalent bond formed when a
hybrid orbital accepts a pair of electrons from a ligand in
such a manner that the electron density is symmetrical about

,.
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the bond axis.

A rr bond, on the other hand, has a minimal

electron density about the bond axis and is formed if the
central atom has loosely held d electrons and the ligand
vacant d orbitals or vice versa.

The rr bond strengthens

the a bond and reduces the negative charge resulting from
the addition of ligands to the central atom.

3.

THE HARD AND SOFT ACID AND BASE CLASSIFICATION OF
LEWIS ACIDS

G. N. Lewis (1923) defined a base as an atom, molecule, or ion having at least one pair of unshared valence
electrons.

An acid was similarly defined as an atom, mole-

cule, or ion having a vacant orbital in which a pair of
electrons can be accommodated.

The typical Lewis acid-

base reaction is:
A

acid

+

:B
base

A:B
acid-base complex.

This generalized Lewis acid-base reaction is the most important of all classes of chemical reactions.
The Lewis acid-base concept classifies all metal ions
as Lewis acids.

Sidgewick (1927) noted that in a classical

coordination complex the metal ion completes a stable electron configuration by accepting electron pairs from ligands.
He, therefore, named Lewis acid-base reactions involving
metal ions with vacant orbitals coordinate bond formation
and coined the terms "acceptor" for the Lewis acid or
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central metal ion and "donor" for the Lewis base or ligand.
It follows that most metal ions tend to form coordination
compounds but the tendency to do so generally increases
with rising electron affinity of the metal.
Lewis acids and bases have been classified by'Pearson
(1968 a and b) into hard and soft acids and bases (HSAB) in
order to provide a general explanation of the stability of
the acid-base complex A:B.

The HSAB principle provides a

qualitative, or, at best, a semiquantitative rule.

It does,

nonetheless, have considerable utility, proving very useful
in predicting which metal will combine most strongly with
which ligand and in correlating and understanding the large
amount of information presently available.
Certain properties of the Lewis acid result in either
a high electropositivity and low polarizability or low electropositivity and high polarizability.

These are general

criteria chosen by Pearson as the basis for the classification of Lewis acids as hard or soft.

Thus some Lewis acids

are small, have a high positive oxidation state, and do not
contain unshared electrons in their valence electron shells.
These properties result in high electropositivity and low
polarizability on the basis of which these Lewis acids are
classified as hard.

On

the other hand some Lewis acids are

large, have a low positive oxidation state, and contain
several unshared electrons in their valence electron shell.
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These properties result in low electropositivity and high
polarizability as a result of which these Lewis acids are
classified as soft.

Borderline acids have intermediate

properties hence behave like hard acids in the presence of
hard bases and behave like soft acids in the presence of
soft bases.

Hard solvents, of which water is one of the

hardest, will partially destroy hard acid characteristics
and enhance soft acid characteristics.
In a similar manner Pearson classified Lewis bases as
hard or soft.

Hard bases contain a donor atom of low polar-

izability and high electronegatively which is difficult to
reduce and is associated with empty, high energy (hence inaccessible) orbitals.

In contrast, soft bases contain a

donor atom of high polarizability and low electronegativity
which is either easily oxidized or associated with empty,
low-lying orbitals.
Pearson formulated the principle of hard and soft
acids and bases as a concise statement summing up the
experimental data used to classify Lewis acids and bases as
hard or soft.

That principle states that the most stable

complexes result from hard acid-hard base and soft acidsoft base combinations.

The type of bond usually associat-

ed with hard acid-hard base bond formation is typically
ionic while that associated with soft acid-soft base bond
formation is typically the covalent (cr) and, under appropriate conditions, the rr bond.

·"La
.. vie est dure" according to Pearson (1966).

That

is, ;hard acids and hard bases are the normal, abundant corn. ··:

pone~t~ of b~ological systems.

Most soft acids and soft

bases·, o.n the other hand, are poisons to living organisms
because t?ey form strong complexes with the soft bases and
soft a'cids present in small amounts in the organism as the
all important active centers of certain enzymes, etc.

,
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E.

THE METAL ION AND ITS ROLE IN ENZY}ffi ACTIVITY

1.

THE ENZY}ffi (Kachmar and Moss, 1976; Lehninger, 1975)
In 1897 Eduard Buchner discovered that sugar can be

made to ferment not only with ordinary yeast but also with
the help of the expressed juices of yeast which contain no
yeast cells.

The discovery of these unknown active sub-

stances called enzymes was so important that Buchner was
awarded the 1907 Nobel Prize for Chemistry (Buchner, 1966).
Wilhelm Ostwald received the 1909 Nobel Prize for Chemistry
for formulating the basic principle of catalysis which says
that a catalyst increases the rate at which a chemical reaction occurs without itself being consumed or permanently
altered (Ostwald, 1966).

Ostwald was the first to point out

that enzymes act as catalysts.

It was not until 1926 when

James B. Sumner crystallized the enzyme urease that enzymes
were recognized as proteins.

For this work Sumner was a-

warded the 1946 Nobel Prize for Chemistry (Sumner, 1966).
It was later demonstrated that the way an enzyme increases
the rate of a biological reaction is by providing a reaction
route having a lower free energy of activation for the transition of substrate to product than the uncatalyzed reaction.
The specific catalytic activity of many enzymes depends solely on the unique amino acid composition and
sequence and the native conformation, or folded state,
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determined by the interaction of amino acid side chains with
each other and the solvent.

Other enzymes, however, require

in addition the presence of some nonprotein entities or cofactors before enzyme activity can be manifested or maximized.

If a cofactor is an organic substance it is

referred to as a coenzyme while if it is an inorganic ion,
such as a metal ion, it is called an activator.
Enzymes are proteins hence heat, extremes of pH, and
various chemicals, including metal ions, can alter their
structure (i.e. denature them).

Denaturation can be wholely

or partially reversible or irreversible depending on the
cause of the denaturation and its duration of action.

Since

the ability of an enzyme to catalyze a specific reaction is
dependent on its unique amino acid composition and sequence
and the precise conformation of the folded polypeptide that
they determine, even slight denaturation can render it
inactive.

2.

THE SULFHYDRYL GROUP AND ENZYME INHIBITION
Sulfhydryl groups (-SH) are chemically the most

active groups found in cells.

As such they react as a class

specifically and often quantitatively with various thiolcombining agents including a wide range of metal ions with
which they form stable complexes (Jocelyn, 1972).

The

reactivity of sulfhydryl groups is due to the fact that they
dissociate to mercaptide ions ( RS-) in aqueous media

p
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which are 500 times more nucleophilic that the corresponding oxygen analogue ( RO-) (Streitweiser, 1956).

Among

factors contributing to the nucleophilicity of the mercaptide group is the ease with which its negative charge and
unshared electrons can be polarized and attracted by electrophilic centers.

Thus sulfhydryl groups, especially

sulfhydryl groups in aqueous media, are soft Lewis bases.
In many enzymes the presence of free cysteine sulfhydryl groups is essential for activity.

Boyer (1959) pro-

vided a general definition of a sulfhydryl enzyme as an
enzyme that loses its catalytic activity when some or all of
its original sulfhydryl groups are chemically modified.
These, like nearly all sulfhydryl proteins, occur intracellularly and are less stable than disulfide proteins due
to the absence of covalent cross links hence they can usually be denatured under mild conditions (Cecil, 1963).

In

vitro oxidation of these groups to disulfide groups (-S-S-)
by dissolved oxygen at neutral and alkaline pH is a typical
example of this.

Often, however, an enzyme denatured in

this manner can be reactivated by treatment with thiols
such as cysteine, mercaptoethanol, dithiothreitol, or reduced glutathione which reduce disulfide bridges to the
free -SH form through a thiol-disulfide interchange
(Haschemeyer and Haschemeyer, 1973).
Sulfhydryl groups within many enzymes vary in reactivity toward various reagents.

The reactivity
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differences of -SH groups of different enzymes and even within the same enzyme molecule is related to their functional
roles as essential catalytic sites in substrate binding and
maintaining protein structure and conformation.

However,

Friedman (1973), after reviewing the literature on more than
40 sulfhydryl enzymes, concluded that the evidence indicating whether the -SH groups of -SH enzymes participate directly in catalysis by, for example, interacting with electrophilic centers of substrates or by maintaining an enzyme conformation required for activity is equivocal.

The mechanism

is difficult to deduce from current techniques of chemically
modifying essential -SH groups because substrate reactions
could be sterically hindered by conformational changes near
the reactive site as easily as they could by a chemical
change in the site itself (Spradlin and Thoma, 1970).
Paul Ehrlich received the 1908 Nobel Prize in Physiology or Medicine for his studies on the relation between toxins and antibodies (Ehrlich, 1967) which resulted
in his well-known side-chain theory, the foundation of
modern receptor theory.

An important conclusion reached by

Ehrlich (1909) as a result of this work was that sulfhydryl
groups act as receptors for metal ions.

Voegtlin and co-

workers (1924) later proved this and also demonstrated that
thiols could counteract the toxic effect of metal ions by a
thiol-mercaptide interchange.
Reactions leading to metal mercaptide formation are
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among the most specific of the varied reactions of the sulfhydryl group (Boyer, 1959).

In most instances when metal

ions are found to inhibit enzymatic activity reaction with
sulfhydryl groups is the first suspected.

Divalent lead,

copper, mercury, cadmium, and zinc and monovalent silver,
all soft or borderline Lewis acids, are those metal cations
most likely to inhibit enzyme activity through the formation
of monodentate metal mercaptides with the sulfhydryl groups
of the cysteine residues of a large number of enzymes
(Vallee and Wacker, 1970).
metal cations for

RS

The marked affinity of certain

is a result of their tendency to ac-

cept electrons in a coordinate covalent bond together with
the willingness of

RS

to donate electrons.

In addition,

~

type bonding with sulfur can occur through overlap involving
d orbitals (Liu, 1977).

The relative magnitude of enzyme

inhibition due to the interaction of metal ions with free
sulfhydryl groups is generally proportional to the solubility products of the metal sulfides (Klotz, 1954).

3.

THE METALLOENZYME AND THE METAL- ENZYME COMPLEX

According to Vallee and Wacker (1970) nearly one third
of all enzymes have metals built into their structure, require added metal for activity, or are further activated by
metal ions.

In 1955 Vallee defined metalloenzymes as en-

zymes which retain stoichiometric, tightly bound, functional
metal ions when purified while a metal-activated enzyme was
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defined as one to which metal ions had to be added for activity.

Malmstrom and Rosenberg (1959) pointed out the fact

that the major difference between metalloenzymes and metalenzyme complexes is a quantitative one; in metal-activated
enzymes the affinity for the metal ion is relatively low
but the role of the metal ion might be the same as in metalloenzymes in which the affinity of the enzyme for the metal
is relatively high.

The rough dividing line between metal-

loenzymes and metal-activated enzymes is a stability constant of 10 8 M-l (Coleman and Vallee, 1961). Borderline
cases do exist in which an enzyme partially retains the
metal activator on purification but an increase in the residual activity is observed upon the addition of metal ions
to the purified enzyme.
The same metal ion may fill several different roles
in the same enzyme and different metal ions may also have
different roles in the same enzyme.

The structural role,

the nature of the ligand, the geometry of the complexes
which produce the effects and their relevence to protein
conformation are sketchy and cannot be categorized with
certainty due to a lack of adequately sensitive experimental approaches.
According to Vallee and Wacker (1970) it is possible
for a metal ion to affect enzyme activity by:
a. ·participating in binding substrates, cofactors,
or both
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b.

activating the enzyme-substrate complex once it is
formed

c.

serving both functions

d.

maintaining secondary, tertiary, or quarternary
structure or interacting with the side chains in
such a manner that the resulting coordination complex can function catalytically

e.

undergoing oxidation-reduction during the enzyme
reaction, transferring electrons in oxidative processes

f.

bringing about changes in conformation that are
either functionally or structurally advantageous
or both

g.

putting the enzyme in a state of entasis, constituting an energetically poised domain.

For most enzymes the available information does not allow
a detailed microscopic differentiation of these possibilities.
In their review of the field Vallee and Coleman (1964)
observed that the metals involved in these enzymatic reactions are limited to the alkaline earths, Ca+2 and
Mg+ 2 , the metals of the second half of the first transition period, the Group IIB metals, and a single metal from
the second transition period, molybedenum.

There is, ac-

cording to these authors, no preferred distribution of
metals among the various enzyme catalyzed reactions except
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for molybdenum and copper.

Molybdenum is encountered ex-

clusively in the metalloflavoproteins and copper enzymes
catalyze a series of oxidation-reduction reactions without
the aid of additional cofactors but copper is not an essential participant in hydrolytic systems.

The alkaline earths

and manganese activate a large number of enzyme systems involving ATP and in many of these instances the first transition metals can also activate.

Zinc

plays a varied role

in metal-enzyme catalyzed reactions, occurring in each of
the six categories of enzymes designated by the International Union on Biochemistry (IUB) commission on enzymes which
are oxidoreductases (e.g. human liver alcohol dehydrogenase;
Von Wartburg et al., 1964), transferases (e.g.

~·

coli DNA

polymerase; Slater et al., 1971), hydrolases (e.g. human
leukocyte alkaline phosphatase; Trubowitz et al., 1961),
lyases (e.g. human erythrocyte carbonic anhydrase; Rickli
and Edsall, 1962), isomerases (e.g. brewer's yeast mannose6-phosphate isomerase; Gracy and Noltmann, 1968), and ligases (e.g. yeast pyruvate carboxylase; Scrutton et al.,
1970).
The number of side chain functions of proteins (including carboxyl, imidazole, and sulfhydryl functions) , of
course, greatly exceeds the number of terminal groups so
these are the important metal binding sites.

There are

always more than are actually needed so each metal ion may
choose which site it prefers on a HSAB basis, the general
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relationship between protein donor atom and the metal preferring it being:

:N, -0

-0

Ca, Mg, Mn

Fe, Co, Ni

:N, -S
Cu, Zn

-s
Cd, Pb, Ag, Hg

The choice of ligand is also determined by factors affecting
the local environment of the ligand including intra- or
inter-molecular hydrogen bonding, electrostatic or hydrophobic interactions, the vicinal effects of charges, and the
stereochemistry of the ligand and the enzyme of which it is
a part.

Different metal ions can and do combine with the

same ligand of a given enzyme but their different geometries could activate the enzyme by providing a three dimensional template or inhibit the enzyme by failing to provide
such a template or disrupting the three dimensional structure of the enzyme.

(Vallee and Williams, 1968; Williams

1971)

4.

THE INTERACTIONS OF METAL IONS IN BIOLOGICAL SYSTEMS
As one considers the trace element requirements of

man and animals numerous interrelationships between essential minerals as well as between essential and nonessential minerals are noted.

A number of trace element

deficiencies arise or are induced by biological interactions
among these minerals.

A trace element deficiency results

from a failure in the supply of an essential nutrient to at
least one of its functional sites.

When the deficiency is
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induced by the presence of antagonists the interaction may
occur at any of these essential loci during gastrointestinal absorption and during incorporation into binding sites
of enzymes and transport, storage, and cellular structural
proteins.

Hill and Matrone (1970) have proposed an explanall

tion for these relationships based on the electronic configuration of the ionic form of the minerals.

Their hypothe-

sis is that "Those elements whose physical and chemical
properties are similar will act antagonistically to each
other biologically."

The interactions of such elements are,

therefore, competitive and, as such, negative and mutual.
Thus the effects of an excessive concentration of an antagonistic element, essential or nonessential, is reversible
if the concentration of the agonist is increased (Bremner,
1974).
There are antagonistic relationships between the ions
of certain elements which have electronic structures that
are not at all similar.

Such noncompetitive interactions

arise when an excess or deficiency of an element influences
the metabolic fate of a second element or interferes with
some biological process essential for the full expression
of its biological activity.

This may happen by the excess

or deficiency of an element inducing or failing to induce
the synthesis of a protein to which the second element binds
or by the excess of a given element forming an insoluble,
nonavailable complex with the second element.

Such
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interactions are generally discovered by empirical observation hence there exist no rules concerning reversibility,
mutuality, or the negative or positive nature of the
interaction.

(Davies, 1974)

The present evidence for a direct competition within
the gastrointestinal tract for binding sites in the transfer of minerals across intestinal membranes is limited.

To

be sure, in the presence of abnormally high levels of one
element and marginal levels of another indirect competition
through the formation of insoluble complexes, a change in
solubility as a result of hydrogen ion concentration, or a
change in the microflora of the gastrointestinal tract with
the consequent sequestering of essential elements can be
crucial.

Nonetheless, it does seem more likely that absorp-

tion competition is minimal when compared with competition
at sites within the body tissues (Davis, 1972).
While similar ions are always antagonistic in vivo
they often show interchangeability in the activation of
certain enzymes in vitro (Matrone, 1970; Vallee and Coleman,
1964).

An important area of future research is the identi-

fication, in vivo, of synergistic interactions among the
elements as well as the substitution of closely related
metals in enzyme structures with a consequent change in
enzymatic activity.

CHAPTER II

RESEARCH OBJECTIVES

CHAPTER II
RESEARCH OBJECTIVES
The purpose of the research described and discussed
in this dissertation was the determination of factors
associated with or affecting an increase or decrease in
mammalian erythrocytic ALAD activity.
The initial objective of the present research was to
determine whether a linear relationship exists between the
degree of reticulocytosis and erythrocytic ALAD activity in
the developing male rat.

This seemed of particular interest

because ALAD activity is often used as an index of the
degree of experimental lead intoxication in the rat.

A

variation of ALAD activity with the age of the animal and
the reticulocytosis present at that age would be an important source of variability in lead poisoning analysis.
Furthermore, if such a relationship does exist this study
might serve to establish the developing rat as a useful
model in which to further investigate whether a decrease in
the activity of the soluble cytoplasmic enzyme with the age
of the red cell is due to a denaturation of the enzyme protein, a decreased concentration of an enzyme activator, or
an increased concentration of an enzyme inhibitor.
It then seemed necessary to establish a reference
value for the erythrocytic ALAD activity of normal, healthy,
nonmedicated adult male and female volunteers and to
70
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determine whether the enzyme activity could be correlated
with gender, age, or reticulocyte percent.

~fuile

this would

add to the present knowledge that both lead and genetic
factors influence the level of erythrocytic ALAD activity,
its main purpose was to establish a screen of the enzymatic
activity of normal adult human volunteers used in the main
section of the present study.
Finally, this research sought to establish a doseresponse curve for the in vitro lead-induced inhibition of
normal adult human erythrocytic ALAD and for the activation
of the enzyme by a metal ion discovered on screening various
potential activators.

It was, therefore, the main purpose

of this study to determine, in a dose-response fashion, the
in vitro effects of the soluble acetate, chloride, or
fluoride salts of Na+, Mg+Z, Al+ 3 , ~fu+Z, Cu+ 2 , Ag+ Zn+ 2 ,
2
2
H +2 G +3 I +3 Pb+ , Sn+ , and Sn+4 on the normal
g

'

a

'

n

'

enzyme and on an enzyme 50% inhibited by Pb+Z while at the
same time examining the ability of a maximally stimulatory
concentration of the activator metal ion to prevent or reverse the effects of these other metal ions.

The effects of

these metal ions were then classified in terms of their oxidation state, valence electronic configuration, characteristic coordination number, coordination geometry, and hard and
soft Lewis acid characteristics in order to determine what
physical and chemical properties are associated with the
ability of a metal ion to activate or inhibit erythrocytic
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ALAD and whether these properties are unique to any
single metal ion.

This could serve to establish the basis

of a future investigation of the actual metal ion requirement of human erythrocytic ALAD as well as of a potential
prophylactic and therapeutic use of nontoxic metal salts in
the prevention and treatment of both pediatric and adult
lead poisoning.

CHAPTER III
MATERIALS AND METHODS

CHAPTER III
HATERIALS AND METHODS
A. THE WHOLE BLOOD SPECIMEN

1. THE ANIMALS
Male Sprague-Dawley rats were obtained from the
Holtzman Rat Company (}fudison, Wise.), rats less than 20
days of age being sent and housed with a nursing dam.

Rats

more than 20 days old were housed no more than 5 animals per
mesh-bottomed stainless steel cage and fed Purina Rat Chow
(St. Louis) ad libitum with uninterrupted access to water.
Animals were maintained in a temperature controlled (22°C)
room under a 12 hour light: 12 hour dark schedule (lights on
0700-1900 hours).
Following ether (Mallinckrodt, St. Louis) anesthesia,
blood was obtained from rats aged 20 days and older by
aortic puncture using a sodium heparinized Vacutainer tube
and an appropriate modification of the technique described
below.

Blood was obtained from younger rats by decapitation

and allowing the blood to drop into a similar Vacutainer
tube.

A complete blood count and reticulocyte percent were

determined for each blood specimen as described below.

2. THE

H~AN

VOLUNTEERS

Blood was obtained from normal, healthy, nonmedicated
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adult male and female volunteers, after obtaining informed
consent, by cubital venipuncture into sodium heparinized
Vacutainer tubes as described below.

When establishing

normal reference values for adult human

~rythrocytic

ALAD

activity, volunteers from 18 to 70 years of age were used.
For the metal ion activation and inhibition studies, blood
was obtained from an equal number of male and female volunteers between the ages of 18 and 30.

As a routine screen

of the volunteers, a complete blood count and reticulocyte
percent were determined for each of the volunteers' blood
specimens as described below.

3. THE ROUTINE VENIPUNCTURE (Miale, 1977)
All equipment used for the routine venipuncture was
dry and sterile.

A tourniquet was applied to the arm of the

volunteer above the elbow just tight enough to prevent the
venous return.

The area over the cubital vein was cleansed

by wiping vigorously for one minute with an alcohol wipe
(Will Ross, Milwaukee) and allowed to air dry.

A 5 ml

heparinized (132 units of sodium heparin) B-D Vacutainer
tube (3206 KA; Becton, Dickinson and Co., Rutherford, N.J.)
was affixed to the adaptor-held 21 gauge/1 inch multidraw
needle (Safe II; Jelco, Raritan, N.J.) so the innermost
shaft of the needle held the stoppered tube in place but did
not penetrate the stopper.

The sheath was removed from the

needle and the vein entered with the bevel of the needle up
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and, with the adaptor held firmly, the Vacutainer tube was
forced onto the needle shaft so the rubber stopper was
penetrated and the blood flowed into the tube.

When the

tube was filled to capacity the tourniquet was released, the
tube was removed from the needle shaft, and the needle was
withdrawn from the vein.

The tube was then gently inverted

several times to allow thorough mixing of the blood with the
anticoagulant, pressure was applied to the site of the venipuncture with a gauze square, and the arm of the volunteer
was elevated to assist in collapsing the punctured vein.
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B. THE HEMATOLOGIC PROFILE

1. THE MICROHEMATOCRIT
Microhematocrits (Hct) were determined in duplicate
using an adaption of the method of Strumia et al. (1954).
A plain capillary tube was filled by capillary action approximately two thirds full with an aliquot of heparinized whole
blood and one end sealed with sealing clay.

The tubes were

then placed in opposite radial groves of an International
micro-capillary centrifuge, Model MB (International Equipment Company, Needham Hts., Mass.), with the sealed end out
against the rubber liner, the centrifuge cover put in place,
and centrifuged at 11,500 revolutions per minute.

The

hematocrit was then read on an International micro-capillary
reader.

Because the hematocrit measured in this manner in-

cludes trapped plasma it is higher than that determined by
calculation on the Coulter Counter Model S but the amount of
plasma trapping in normal subjects is only 3% (England et
al., 1972).

2. THE COMPLETE BLOOD COUNT
The complete blood count (CBC), which includes the
hemoglobin (Hb), hematocrit (Hct), red blood cell count,
mean corpuscular volume (MCV) , mean corpuscular hemoglobin
(MCH), mean corpuscular hemoglobin concentration (MCHC), and
white blood cell count, was determined on heparinized whole
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blood using the Coulter Counter Model S (Coulter Electronics,
Hialeah, Fla.) as described and assessed by Pinkerton and
co-workers (1970).

This instrument consists, in effect, of

three Coulter counters electronically counting and sizing
red cells and three electronically counting white cells
together with a photosensitive device for measuring Hb concentration as cyanmethemoglobin.

From the Hb, red cell

count, and MCV, which it measures directly on 44.7

~1

of

whole blood appropriately diluted by the instrument, the
Coulter Counter Model S electronically calculates the Hct,
MCH, and MCHC using the following relationships:
Hct

=

MCH =

MCHC =

MCV x red blood cell count

10
Hb

X

10

red blood cell count
Hb

X

100

Hct
The precision and accuracy of the results obtained with the
Coulter Counter

~1odel

S are reported to be much better than

that of careful manual estimates and at least comparable to
that of other automated equipment.

3. THE RETICULOCYTE COUNT
The new methylene blue method for staining reticulocytes (Brecher, 1949) was employed.

The staining solution

consisted of 0.5 g of the supravital stain new methylene
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blue Nand 1.6 g of potassium oxalate (which acts as an anticoagulant and makes the staining solution isotonic) (Harleco,
Gibbstown, N.J.) dissolved in 100.0 ml of distilled water.
The solution was filtered before use.
Approximately 100

~1

each of staining solution and

fresh or heparinized whole blood were mixed in a small cup
and allowed to stand for 20 minutes.

After staining, thin

smears were made and allowed to air dry before counting.
The number of reticulocytes encountered while 1000
erythrocytes were examined under oil immersion was then
determined.

A reticulocyte was considered to be any erythro-

cyte containing two or more granular or reticulum-like
inclusions with the appropriate staining characteristics
since one cannot be certain a single refractile blue granule is a remnant of reticulum (Seip, 1953).

The number of

reticulocytes counted in this manner divided by 10 was taken
to be the percent of reticulocytes present.
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C. THE DETEru1INATION OF ERYTHROCYTIC ALAD ACTIVITY

1. THE BASIC ALAD ASSAY
All current in vitro assays for erythrocytic ALAD are
based on the properties of the enzyme described by Gibson et
al. (1955) and Granick and Mauzerall (1958b).

Bonsignore

and associates (1965) developed the first clinically useful
test for erythrocytic ALAD activity because they demonstrated that it is not necessary to conduct the assay either
under nitrogen or in vacuo and it is not necessary to wash
the red cells.

This method was subsequently modified by

Weissberg and associates (1971) who conducted the assay on
micro samples of blood and by Burch and Siegel (1971) who
introduced a more stable buffer.

Erythrocytic ALAD was

determined in the present study using an adaptation of the
whole blood micro-methods of Weissberg et al. (1971) and
Burch and Siegel (1971) (FIGURE 2) .
A 0.1 ml aliquot of heparinized whole blood, drawn
into a 100

~1

disposable micropipet, was.hemolyzed in 1.5 ml

of aqeous 0.2% Triton X-100 (cetyl phenoxy polyethoxyethanol;
Sigma, St. Louis).

The hemolysate was ·warmed to 37°C for

5 minutes following which 1.0 ml of freshly prepared 0.01 M
ALA"HCl (Sigma) in 0.25 M dibasic sodium phosphate heptahydrate (Mallinckrodt)/citric acid (Fisher, Fair Lawn, N.J.)
buffer.

At the end of a 1 hour incubation at 37°C the

reaction was stopped by the addition of 1.0 ml of a 10%
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trichloroacetic acid (Mallinckrodt) solution which also contained 0.02 M N-ethyl maleimide (Sigma) followed by the
immediate addition of 0.05 ml of a saturated cupric sulfate
pentahydrate (Baker, Phillipsburg, N.J.) solution.

After

standing for 5 minutes the mixture was centrifuged at
600 x g for 10 minutes at room temperature.

A 2.0 ml

aliquot of the supernatant was withdrawn and 2.0 ml of fresh
Ehrlich's reagent, prepared as described below, was added.
After 15 minutes the optical density was read at 555 nm
using a 1.0 em light path cuvet in a Bausch and Lomb Spectronic 20 colorimeter (Rochester, N.Y.) set to 100% transmission with a reagent blank in which water was substituted
for blood since the absorbance of a blank is negligible compared to that of a reagent blank.
A milliunit (mU) of erythrocytic ALAD activity is defined (FIGURE 3) as the amount of enzyme that will catalyze
the transformation of 1 nH of PJ.....A to PBG per minute at pH
6.7 and 37°C.

Erythrocytic PJ.....AD activity is expressed as

mU/ml of packed red blood cells and was defined by the
following formula:
ALAD mU/ml RBC =

on 60

x (100/Hct) x 40.56

where:

on 60 =

the optical density after incubation of the
hemolysate with the substrate for 1 hour at
37°C

Ret = the microhematocrit determined as described above
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(3.65 x 2) (the blood dilution)

40.56 =

0.1 (the blood volume) x 60 (the incubation time)
1
X

0.060 (the optical density of 1 nM of PBG/ml)
x 2 (2 molecules of ALA yield 1 molecule of PBG).
The PBG extinction coefficient determined under these experimental conditions is in exact agreement with that described
in the literature (Mauzerall and Granick, 1956; Burch and
Siegel, 1971).
Triton X-100 is a non-ionic surfactant (soluble amphiphile) that, at the concentration used in the present study,
ensures immediate and complete lysis of the erythrocytes.
While the molecular mechanism of lysis is unknown, the lytic
process is known to consist of five steps:
a. the surfactant adsorbs to the cell membrane
b. the surfactant penetrates into the cell membrane
c. the surfactant induces a change in the molecular
organization of the cell membrane
d. the change in molecular organization results in
a change in the permeability of the cell membrane
and a consequent change in the osmotic equilibrium
across the cell membrane
e. once the osmotic equilibrium is sufficiently offset
and proteins and other macromolecules begin to pass
through the membrane lysis has occurred.

jiP'
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Triton X-100, however, does not induce conformational
changes in soluble cytoplasmic proteins leading to a loss of
their biological properties hence is safe to use for lysis
of erythrocyte membranes so the activity of a soluble cytoplasmic enzyme (such as ALAD) can be studied.
Simons, 1975)

(Helenius and

Mitchell and co-investigators (1977) found

that results obtained on erythrocytes hemolyzed in 0.2%
Triton X-100 are not significantly different than results
obtained on freeze-thaw hemolyzed erythrocytes.
The bicarbonate buffered ALA substrate prepared according to the method of Bonsignore and associates (1965) does
not provide adequate buffering capacity, the pH increasing
from an initial pH of 7.0 to a final pH of 8.2 after 1 hour
of incubation (Burch and Siegel, 1971; Finelli et al., 1974),
thus could not be used.

In addition, the use of potassium

ions in the buffer (as in all other reagents) had to be carefully avoided since K+ reacts with perchloric acid in the
modified Ehrlich's reagent resulting in the formation of a
very fine potassium perchlorate precipitate which can interfere with the assay by falsely elevating the absorbance
readings (Finelli et al., 1974) unless removed by low-speed
centrifugation (Mitchell et al., 1977).

Therefore the buf-

fer employed was an extremely stable 0.25 M dibasic sodium
phosphate heptahydrate/citrate buffer which maintained the
pH of the incubation mixture at the optimum pH found for the
normal enzyme, 6.70

± 0.05

(Burch and Siegel, 1971) even
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when very large concentrations of metal ions were added
(Hitchell et al., 1977).

Furthermore, although phosphates

often form insoluble salts with metal cations, the phosphate
used in the present buffer system does not interfere with
the determination of erythrocytic ALAD activity even when
the metal ions are added up to a concentration of 10 -2 M
(Mitchell et al., 1977).
In the determination of erthrocytic ALAD activity the
product of the action of ALAD, PBG, is measured colormetrically.
tuted

In the color reaction PBG condenses at its unsubstia:

position in acidic solution w·ith D¥..AB, which is

present is large excess, to form a colored condensation
product, rnonopyrrylphenylrnethane, the intensity of which
increases rapidly and diminishes slowly.

The color salt can

further react with another molecule of PBG to form a colorless dipyrrlphenylrnethane but with excess DMAB this reaction
is very slow.

(Mauzerall and Granick, 1956) Sulfhydryl corn-

pounds decolorize the pink salt formed by the reaction of
the Ehrlich's reagent with PBG (Granick and Hauzerall, 1958b).
Sulfhydryl interference can be prevented by tying up the
sulfhydryl groups with N-ethyl rnaleirnide (Burch and Siegel,
1971) or Cu+ 2 (Gibson et al., 1955); in the present procedure both of these methods of removing sulfhydryl interference were employed.
Fresh Ehrlich's reagent was prepared in the following
manner (Davis and Andelman, 1967; Davis et al., 1968;
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Bio-Rad, 1968): 10 g of p-dimethylaminobenzaldehyde (DMAB;
MCB, Norwood, Ohio) was added to 420 ml of glacial acetic
acid (Mallinckrodt).

This mixture is stable for several

months when kept in a refrigerator at 4°C where it will
solidify.

Subsequent thawing on the day of the analysis

was performed by running warm water over the outside of the
bottle containing the acetic acid solution containing the
added DMAB following which 19 ml of 72% perchloric acid
(Mallinckrodt) was added to every 100 ml aliquot of the
acetic acid solution containing the added DMAB.

2. THE DETERMINATION OF THE EFFECT OF METAL IONS ON ERYTHROCYTIC ALAD ACTIVITY
The effects of various metal ions, alone and in combinations, on erythrocytic ALAD were studied (FIGURE 4).
The metal ions were added by substituting an 0.1 ml aliquot
of a freshly prepared solution of a given concentration of
the metal ion to be studied for 0.1 ml of the 1.5 ml of
aqueous 0.2% Triton X-100 solution in which the whole blood
was hemolyzed.

Soluble acetate, chloride, or fluoride salts

of the metal ions were used after all effects of the acetate,
chloride, and fluoride ions on erythrocytic ALAD activity
were ruled out.

The solutions were prepared in aqueous 0.2%

Triton X-100 unless flocculation was observed in which case
they were prepared in water.

The 0.1 ml aliquots were added

immediately after the 5 minute preincubation period or, in
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the case of the preincubation studies to be discussed below,
before or after the extended preincubation periods.

When

added in combination an ion being studied for its ability to
activate ALAD was always added after an ion known to inhibit
ALAD while an ion being studied for its ability to inhibit
ALAD was always added before an ion known to activate ALAD.
Several metal ions were initally screened for their
effect on human erythrocytic ALAD over a wide concentration
range and, as discussed below, Pb+Z was identified as an inhibitor of ALAD and zn+ 2 was identified as an activator of
ALAD.

The remaining ions were screened, over a broad con-

centration range, for their effect on the normal enzyme and
on an enzyme preparation 50% inhibitied by lead (the In 50
Pb+Z concentration). In addition, that concentration of
zn+ 2 able to maximally stimulate the enzyme (the sn 100 zn+2
concentration) was examined for its ability to prevent or
reverse the possible inhibition caused by the metal ions
being studied.
In order to further investigate the effects of several
metal ions of interest preincubation studies were conducted.
Solutions of the metal salts were added to hemolysates immediately before or after preincubation periods of 0.5, 1.0,
2.0, and 4.0 hours in order to determine if the observed
effect of the metal ion was potentiated, unchanged, or
reversed by prolonged exposure of the enzyme to the cation.
Insofar as it was possible, all studies were conducted
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in such a manner that paired data could be gathered.

That

is, for a given blood sample the control ALAD activity

~vas

determined for the normal enzyme and, as appropriate, for
the enzyme 50% inhibited by Pb+Z and maximally stimulated by
Zn+Z at the same time the effect of metal ions on the normal,
Pb+ 2 -inhibited, and Zn+2 -stimulated ALAD was being determined on other aliquots of the same blood specimen.

All

data was expressed as a percent of the normal, uninhibited,
unstimulated, nonpreincubated erythrocytic ALAD activity for
that specimen but statistical comparisons were made only on
raw erythrocytic ALAD activities.
All metal salts used were American Chemical Society
approved analytical reagents whenever these were commercially available as were all other reagents.

Distilled water

was used in the preparation of these and all other aqueous
solutions.

The metal salts employed were:

Na(CH 3 COO) '3 H2o (Mallinckrodt)
NaCl (Baker)
NaF (MCB)
Mg(CH 3COO)z'4 HzO (MCB)
Alc1 ·6 H2o (Mallinckrodt)
3
Mn(CH 3 COO)z'4 H2o (HCB)
Cu(CH coo) 2 ·H 2 o (Mallinckrodt)
3
Ag(CH 3COO) (HCB)
Zn(CH C00) 2 ·z H2o (Mallinckrodt)
3
Cd(CH C00) 2 ·z H2o (MCB)
3
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Cdc1

2 ·2~ H2o (Mallinckrodt)

HgC1 2 (Mallinckrodt)
GaC1
InC1

3
3

(Apache, Rockford, Ill.,)
(K & K, Plainview, N.J.)

SnF 2 (Alfa, Danvers, Mass.)
snc1 4 ·s H2o (Mallinckrodt)
Pb(CH 3COO)z"3 H20 (Baker).
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D. THE STATISTICAL ANALYSIS

Standard statistical methods were used to determine
means, standard deviations, standard errors, nonpaired or
Student's t values, paired t values, slopes, intercepts, and
correlation coefficients (Goldstein, 1964; Sokol and Rohlf,
1969).

1. THE MEAN, STANDARD DEVIATION, AND STANDARD ERROR

A statistic of location describes the position of a
sample along a given dimension representing a variable; such
a statistic is, therefore, a measure of central tendency and
will yield a representative value for the sample of observations.

The arithmetic mean, commonly referred to as the

mean or average (x), is the most important statistic of
location.

The mean was calculated using the following

formula:

x=

n

Z: x. /n

i=l

~

where:
n = the total number of observations
n

~

= the sum of the observed values from the first

i=l
observation through the last.
A statistic of location alone does not completely
describe the shape of a frequency distribution; this is done
by a statistic of dispersion.

The standard deviation, s,

is the statistic most commonly employed for describing
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dispersion in the same units as those of the mean.

The

standard deviation is the distance measured along the x-axis
from the center of the normal distribution curve (the mean)
to the point of inflection of the curve which is its steepest point.

The area under the curve at this distance mea-

sured on either side of the mean (i.e.
69% of the area of the curve while

x~

x ± s)

represents

1.96 s represents

95% of the area and x- +
- 2.58 s represents 99% of the area.
The standard deviation was calculated using the following
formula:
n
- 2 I (n-1)) k2
s = ( 2: (x. -x)
1
1.
1.=
0

where:
n

~

- 2

(xi-x)

= the sum of the squares of the deviations

i=l
of all of the observed values from the
mean of the observations.
The standard error of the mean or the standard error,
s-X' is the standard deviation of the sample means and is
therefore a measure of the reliability of the estimated mean.
It was calculated using this relationship:
s-=s/(n)
X

k2

2. THE NON-PAIRED OR STUDENT'S t-TEST
When one wishes to determine whether or not two sample
means come from the same population one begins with the null
hypothesis and assumes both samples are indeed drawn from
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the same population.

The hypothesis is rejected if the

sample means differ from each other more than random sampling variations would lead one to predict, assuming variances to be homogeneous.

To this end the non-paired or

Student's t-test was performed which compares the magnitude
of the observed difference between sample means with an
estimate of its standard error using the formula:
t

=

(x 1 -x 2 )/s<-xl-x2
- )

where:

xl = the mean of sample 1

x2 = the mean of sample 2

s(x -x 2 ) =the estimate of the standard error of the
1
difference between sample means

= (s 2 ((1/n 1 )+(1/n 2 )))~
s

2

nl
- 2
=( ~
(x . -x )
+
1
1
. 1

~=

~

= the pooled variance estimate
n 1 = the total number of observations in sample 1
n 2 = the total number of observations in sample 2
and a table of critical values of t was entered w·ith ( (n 1 -l)

+ (n 2 -l)) degrees of freedom for the two-tail test.
3. THE PAIRED t-TEST
When two samples of data are obtained on the same subjects, the variability due to differences between subjects
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is eliminated and one considers only the difference in the
response of the subjects to a treatment.

The paired t-test

tests whether the mean of sample differences between pairs
of readings is significantly different from a hypothetical
mean, which the null hypothesis establishes as zero.

The

paired t value was determined using the following relationship:

where:
a = the mean difference between the paired observations
sa

=

the standard error of the mean difference, a

and a table of critical values of t was entered with (n-1)
degrees of freedom for a one-tail test since the hypothesis
about a treatment effect specifies its direction,
where:
n = the total number of paired observations.

4. THE LINEAR REGRESSION AND CORRELATION COEFFICIENT
The equation of a straight line is:
y=mx+b
where:
m = the slope of the line or, in a linear regression
analysis, the regression coefficient
b = the intercept on the y-axis.
The object of a linear regression analysis is to choose, as
a best estimate, a "least squares" line for the data points
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by establishing a line from which the sum of the squared
deviations of the observed y and the predicted y are minimal.
To this end the slope was calculated using this formula:
n

n

n

~

. 1

~ (yi)

L(xi)
x.y. - i=l

~=

~

i=l

~

n

m=
n

2:: x

2

i=l

n
2
-. ( ~ x) /n
i=l

and the y-intercept was calculated using the formula:
n

n

2:_y. -m~x .

b =

. 1

~=

. 1

~

~=

~

n

To determine whether or not a linear correlation
between two variables x and y is strong or weak one calculates the correlation coefficient, r.

For this purpose the

following formula was employed:
r

= (s X /s y )m

where:
sX

= the standard deviation of

sy

= the standard deviation of y.

X

The value of r may vary from 0, indicating no correlation,
to +1 or -1, indicating perfect positive or negative correlation.
sion:

The significance of r was estimated from the expres-
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and a table of critical values of t was entered with (n-2)
degrees of freedom for the two-tail test.

5. THE LEVEL OF SIGNIFICANCE
Upon correctly entering a table of critical values of
t a P value can be assigned to the difference between sample
means, to the difference between the mean of the difference
between pairs of observations and the hypothetical difference, and to the strength of a linear correlation which
indicates the probability of an observed event occurring by
chance.

When P < 0.05, indicating that the observed event

occurs less ·that 5% of the time by chance, the observation
was considered to be significant.

When P < 0.01, indicating

that the observed event occurs less than 1% of the time by
chance, the observation was considered to be very significant.

When P < 0.001, indicating that the observed event

occurs less than 0.1% of the time by chance, the observation was considered to be highly significant.

6. THE DISPLAY OF STATISTICAL DATA (Feinstein, 1976)
In order to communicate data what is found should be
shown by providing an indication of the central tendency of
the data (the mean) and its dispersion (the standard deviation).

The standard error is not a summary of evidence

hence it is not entirely proper to use it in summarizing
data but its use is justified if the reported results are
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immediately subjected to inferential testing (tests yielding
p values).

If no inferential tests are performed the only

role of standard errors is to distort and conceal data.
This is so because the data looks "tighter" if it is represented as the mean plus or minus the standard error rather
than the mean plus or minus the standard deviation which,
though larger than the standard error, is truely a summary
of the dispersion of the data.
If a graphical illustration of statistical significance is desired a set of 95% confidence interval bars for
the means, calculated using the pooled variance estimate for
groups as calculated in testing the null hypothesis for
the non-paired t-test, is preferred.

If the 95% confidence

intervals around two means do not overlap the difference
between them is significant at P < 0.05.
In the present dissertation data is communicated
graphically as the mean plus or minus the standard error in
order to describe the expected form of the curve not the
dispersion of the data.

Inferential testing. was performed

on the raw data from which the graphs were constructed and
the level of significance is indicated in the text where
it is appropriate.

If the reader wishes to know the disper-

sian of the data about the means in most cases it is only
necessary to double the standard error in order to get the
standard deviation since then is usually 4.

However,

statistically significant differences cannot necessarily be

I

'i
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inferred from the graphs since 95% confidence intervals
are not indicated.

CHAPTER IV

RESULTS

CHAPTER IV
RESULTS
A.

THE CORRELATION OF ERYTHROCYTIC ALAD ACTIVITY WITH BLOOD
RETICULOCYTE PERCENT IN THE DEVELOPING MALE ALBINO RAT
The variation of several hematologic indices and body

weight with the age of the male albino rat is indicated in
FIGURE 5.

Both the hemoglobin (Hb) and the hematocrit (Ret)

were observed to decrease in animals from 3 to 12 days of
age.

Following the initial drop, both of these values rose

steadily from 12 days of age to 50 days of age when these
indices were observed to plateau.

On

the other hand, both

the mean corpuscular volume (MCV) and the mean corpuscular
hemoglobin (MCH) decreased markedly in animals from 3 to 12
days of age after which the values remained constant for the
remainder of the age span studied.
FIGURE 6 illustrates the variation of the blood reticulocyte percent (Ret%) with the age of the male albino rat.
As with the MCV and the HCH, a rapid decrease in the reticulocyte percent was observed.

The reticulocyte percent

decreased from nearly 50% at age 5 days to 35% at 8 days of
age and to approximately 25% at 12 days of age.

This was

followed by a slower decrease to approximately 10% at age
35 days after which the reticulocyte percent appeared to
plateau at just under 5%.
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The mean peripheral blood values for the developing
rat illustrated in these two figures are in excellent agreement with the values reported in the literature (Lucarelli
et al., 1964; Lucarelli et al., 1968).

The unique picture

of a macrocytic hypochromic anemia seen in the early neonatal period of the rat is observed to progress to a normocytic, normochromic state shortly after the onset of puberty
at 30 days of age and through the age of 93 days which was
the limit of the present study.
Erythrocytic ALAD activity was also found to decrease
as a function of the age of the developing male albino rat
(FIGURE 7).

The ALAD activity of a 5 day old rat was near-

ly 55 mU/ml RBC.

This decreased rapidly to 40 mU/ml

8 days of age and to 30 mU/ml RBC at 12 days of age.

P~C

at

The

rapid decrease in erythrocytic ALAD activity during the
early neonatal period was followed by a slower decrease to
15 mU/ml RBC at 40 days of age and to approximately 5 mU/ml
RBC thereafter up to 93 days of age.
The similarity of the relationship between the reticulocyte percent and the age of the male albino rat to the
relationship between the erythrocytic ALAD activity and the
age of the male albino rat suggested that there might be a
linear relationship between erythrocytic

A~AD

activity and

blood reticulocyte percent in the developing rat.

FIGURE 8

shows erythrocytic ALAD activity plotted as a function of
the reticulocyte percent for each of the male albino rats
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studied.

Linear relationship between erythrocytic ALAD

activity and the reticulocyte percent was observed which
can be described by the equation:
y

= 1. 2x + 3. 5

where:
y = the erythrocytic ALAD activity in mU/ml RBC
x = the reticulocyte percent.
This linear relationship has a correlation coefficient of
0.967 and a P value of less than 0.001; no significant
correlation was observed for the relationship between erythrocytic ALAD activity and any other measurement made in the
present study.

These data, therefore, indicate that the .

proportional relationship that exists between erythrocytic
ALAD activity and the number of reticulocytes in the peripheral blood of the developing male albino rat is highly
significant.
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B.

THE GENDER-RELATED DIFFERENCES IN THE REFERENCE VALUES
FOR THE NORMAL ADULT HUMAN ERYTHROCYTIC ALAD ACTIVITY
The important reference values obtained for the sample

population of normal, healthy, nonmedicated adult human male
and female volunteers studied, including age, Hb, Ret, Ret%,
and erythrocytic ALAD activity are presented in TABLE 1.
Blood was obtained from 57 male volunteers having an average
age of 36.3 years and from 49 female volunteers having an
average age of 37.9 years; there was no statistically significant difference between the mean ages of the male and
the female volunteers.

There was also no statistically sig-

nificant difference between the mean reticulocyte percents
of the male and the female volunteers, the mean for both
genders being 1.2%.

There was, however, the expected

(Harris and Kellermeyer, 1970) highly significant (P < 0.001)
difference in the mean Hb and the mean Ret of the male and
the female volunteers due to a difference in the level of
androgenic hormone (McCullagh and Jones, 1942; Kennedy and
Gilbertson, 1957) which enhances the production of erythropoietin as a result of a renotrophic effect (Mann et al.,
1968) and enhanced production of renal erythropoietic factor
(Rencricca et al., 1969); the mean male Hb of 15.4 g/100 ml
and Ret of 45.5% is approximately 10% greater than the mean
female Hb of 13.6 g/100 ml and Ret of 40.9%.

In contrast,

the mean female erythrocytic ALAD activity of 48.2 mU/ml RBC
was found to be very significantly (P

<

0.01) greater than

102
the mean male erythrocytic ALAD activity of 44.2 mU/ml RBC.
These values were normally distributed and there was no
statistically significant correlation between erythrocytic
ALAD activity and any other measurement made in the present
study.
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C.

THE ACTIVATION AND INHIBITION OF NORl1AL ADULT Hill'f..AN
ERYTHROCYTIC ALAD BY 1:-1ETAL IONS IN VITRO
In light of the numerous contradictory reports con-

cerning the effect of metal ions on ALAD activity it became
of interest to investigate the effects of various metal ions
on normal adult human erythrocytic ALAD activity in vitro.
As indicated above, these results were determined only on
blood specimens obtained from normal, healthy, nonmedicated
adult male and female volunteers with both a normal CBC and
a normal erythrocytic ALAD activity.
The first metal ion studied was Cu+ 2 (FIGURE 9), which
was found to inhibit ALAD at very low concentrations.
very significant (P

A

0.01) inhibition of ALAD to 72.5% of
the control activity was observed at 9.3 x 10- 7 M Cu+ 2 and
higher concentrations of Cu+ 2 resulted in highly significant
<

(P < 0.001) inhibition of ALAD.

That concentration of Cu+2

causing 50% inhibition of ALAD (In 50 ) was determined to be
2.5 x 10- 6 M while that concentration of Cu+2 causing 90%
inhibition of ALAD (In 90 ) was determined to be 1.5 x 10-S M.
It seemed quite natural to next determine the effect
of Pb+ 2 on erythrocytic ALAD activity (FIGURE 10). Pb+ 2
inhibits ALAD At very low concentrations, a highly significant (P < 0.001) inhibition of ALAD was observed at 9.3 x
10- 7 H Pb+2 and all higher concentrations. The rn
for
50
Pb+2 was found to be 1.9 x 10- 6 M. While no Pb+2 concentration was found to inhibit ALAD more than 90%, the lowest
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was determined to be 9.3 x 10- 6 M.
90
The effect of zn+ 2 on human erythrocytic ALAD was

Pb+2 In

determined next (FIGURE 10) and it was found to markedly
stimulate ALAD. Over a concentration range of 1.9 x 10 -5 M
-4 ',
to 9.3 x 10
M, zn+2 was found to cause a highly significant (P

0.001) activation of erythrocytic ALAD. The con.
f Zn + 2 caus~ng
.
.
.
.
f ALAD
centrat~on o
a max~mum
act~vat~on o
<

(SD 100 ) was 3.7 x 10 -4 M and at that concentration the
activity of ALAD was 157% of the control activity. At concentrations of 1.9 x 10- 5 M and above zn+ 2 inhibited ALAD
activity.
Cadmium and mercury are, like lead and copper, heavy
metals inhibiting enzymes with functional sulfhydryl groups
but they are also, like zinc, members of Group IIB of the
Periodic Table hence have physical and chemical properties
similar to those of zinc.

For this reason it was of interest to discover the effects of Cd+2 and Hg+2 on ALAD activity (FIGURE 10) .
H +2 like Pb + 2 and
g '
concentrations.

cu+2 '

inhibits ALAD at very low
At a concentration of 4.0 x 10- 6 M, Hg+2

caused a very significant (P
activity.

0.01) 9% decrease in ALAD
At concentrations of 10- 5 M and above, Hg+2
<

caused a highly significant (P < 0.001) decrease in erythrocytic ALAD activity. The ID 50 for Hg+2 was 6.0 x 10- 6 M.
Low concentrations of Cd+ 2 , like zn+ 2 , activate erythrocytic ALAD. At a concentration of 10- 6 M Cd+2 caused a
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significant (P

<

0.05) increase in ALAD activity.

Very

significant (P < 0.01) increases in ALAD activity were observed at the sn 100 , 4.0 x 10- 6 M, and at 10- 5 M Cd+ 2 , the
maximum activity resulting from Cd+2 activation being 134%
of the control activity. At higher concentrations Cd+2
caused a highly significant (P < 0.001) inhibition of ALAD,
the ID 50 being 10- 4 M cd+2 .
Having demonstrated not only the inhibition of erythrocytic ALAD by Pb+2 , Cu+2 , and Hg+2 but also its activation
by Zn+2 and Cd+2 , the obvious question was whether or not
an activator of ALAD could prevent or reverse the effect of
an inhibitor. To that end the effects of zn+2 on an enzyme
inhibited by ID 50 Pb+2 or In 90 Pb+2 (FIGURE 11) and on an
enzyme inhibited by In 50 Cu+2 or In
Cu+2 (FIGURE 12) were
90
determined and reactivation of the inhibited enzyme was
observed.
It was found that zn+2 is able to prevent or reverse
the ID5o Pb + 2 - and ID5o Cu+2 -induced inhibition of erythrocytic ALAD (FIGURE 13). While In 50 Pb+2 caused a highly
significant (P < 0.001) decrease in ALAD activity, all concentrations of Zn +Z from 1. 9 x 10- 5 M to 1. 9 x 10- 3 M
caused a highly significant (P

<

0.001) increase in the

activity of the inhibited enzyme. Indeed, at concentrations
of 1.9 x 10- 4 M zn+2 and above there was no difference from
the activity of the zn+2 activated control. In a similar
manner, In
Cu+ 2 caused a highly significant (P < 0.001)
50
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decrease in ALAD activity which was prevented or reversed
by Zn+2 at concentrations from 9.3 x 10- 5 M to 9.3 x 10- 3 M.
While zn+ 2 caused a highly significant (P < 0.001) increase
in the activity of ALAD with respect to the activity of the
ID 50 Cu+2 control, the reactivation of ALAD was not as
complete as that observed for Pb+2 -induced inhibition. In
fact, the maximum activity observed when zn+2 was added to
. h"b"
t h e ID 50 Cu + 2 Ln
L Lte d enzyme was 106~~ o f t h e centro 1
activity at 3.7 X 10- 4 M zn+2 .
The highly significant (P < 0.001) inhibition of
erythrocytic ALAD by In 90 Pb +2 was also prevented or reversed by 1.9 x 10- 5 M to 1.9 x 10- 3 M zn+2 (FIGURE 14).
~~ile at zn+2 concentrations below 9.3 x 10- 4 M there was a
significant decrease from the activities observed in the
presence of those concentrations of zn+2 alone, the increases in activity were still highly significant (P < 0.001).
Indeed, at 1.9 x 10- 4 M and 3.7 x 10- 4 11 zn+ 2 the ALAD
activities were 107% and 134% of the uninhibited control
activities, respectively, despite the presence of In 90 Pb+2
zn+2 was unable to similarly prevent or reverse the highly
significant (P < 0.001) ID
Cu+ 2 -induced inhibition. Only
90
.
at Zn+2 concentratLons
o f 3.7 x 10 -4 M to 1.9 x 10 -3 M were
very significant (P < 0.01) increases in ALAD activity observed and then the maximum activity observed was only 25%
of the uninhibited control ALAD activity at 1.9 x 10- 3 M.
These results raised the question of which physical
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and chemical properties are associated with the ability of
a metal ion to activate or inhibit human erythrocytic ALAD.
A natural corollary of this question is whether or not these
properties are unique to a single metal ion.

In order to

answer this question various metal ions having physical and
chemical properties similar to those of zn+2 or Pb+ 2 or
those previously reported to activate or inhibit ALAD were
selected and their effects on both normal human erythrocytic
ALAD and on normal erythrocytic ALAD inhibited by ID 50 Pb+2
were determined. In addition, the ability of sn 100 Zn+ 2 to
prevent or reverse the effects of these various ions was
determined.

In all cases the control inhibition of erythrocytic ALAD by ID 50 Pb+2 and the control activation of the
enzyme by sn 100 Zn+2 were at least very significantly
(P

<

0.01) different from the uninhibited and unactivated

control erythrocytic ALAD activity.
FIGURE 15 illustrates the results obtained for Pb+2 ,
In this figure it will be noted that,
while the borderline Lewis acid Pb+ 2 at concentrations of
9.3 x 10- 7 M and above cause a highly significant (P < 0.001)
inhibition of adult human erythrocytic ALAD, 3.7 x 10 -4 M
Zn+2 completely prevented or reversed this inhibition even
at very high concentrations of Pb+ 2 where a slight, albeit
insignificant, decrease in the activity of the zn+2 activated enzyme was observed. The soft Lewis acid Hg+ 2 similarly caused a highly significant inhibition of ALAD at
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concentrations of 4.0 x 10- 6 M and greater but this inhibi+2
tion could not be prevented or reversed by sn 100 Zn
and
Hg+2 did not prevent or reverse the inhibition of ALAD by
ID 50 Pb+2 . Instead, the inhibition caused by Hg+2 at
concentrations above 10- 5 M was additive with both the
stimulation by zn+ 2 and the inhibition by Pb+2 in a highly
significant (P

<

0.001) and a very significant (P

<

0.01)

manner, respectively.

As has already been discussed, the
borderline Lewis acid Zn+2 not only caused a highly significant (P

0.001) activation of ALAD at concentrations from
1.9 x 10-S M to 9.3 x 10- 4 M but also completely prevented
+2
or reversed the effects of In 50 Pb
ove.r a concentration
range of 1.9 x 10-S M to 1.9 x 10- 3 M. The soft Lewis acid
Cd+2 caused a significant (P < 0.05) to highly significant
(P

<

0.01) increase in ALAD activity over the concentration
range of 10- 6 M to 10-S M. Cd+2 from 10-S M to 4.0 x 10- 4 M
. duce d ~n
. h.~ b.~t~on
.
a 1 so prevente d or reverse d t h e ID 50 Pb + 2 -~n
of ALAD, causing a very significant (P < 0.01) increase in
<

ALAD activity to as high as 111% of the uninhibited control
. .
10-S 1..1
act~v~ty at
~.
At concentrations of 4.0 x 10 -5 M and
above Cd+2 caused a highly significant (P < 0.001) inhibition of ALAD that could not be prevented or reversed by
SDlOO zn+2.
In FIGURE 16 the effects of the hard Lewis acids Na+,
Pb+ 2 inhibited, and
Mg+2 , Al+ 3 , and Mn+ 2 on normal, In
50
sn 100 Zn+2 stimulated ALAD are illustrated. It will be
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li
noted that over a concentration range of 1.9 x 10- 6 M to
1.9 x 10- 3 M Na+ had no effect on the normal, Pb+2 inhibited,
or zn+2 activated enzyme. Similarly, Mg+2 and Mn+ 2 had no
effect on the normal, Pb+2 inhibited, or Zn+2 activated

II

II

enzyme at concentrations from 10- 7 M to 10- 3 M. Except at
concentrations above 4.0 x lo- 3 M Al+ 3 had no effect on
normal, Pb+2 inhibited, or zn+ 2 activated ALAD. At 10- 2 M
Al+3 caused a highly significant (P < 0.001) decrease in
ALAD activity to 49% of the control activity hence this was
considered to be the Al+ 3 rn 50 . This inhibition by Al+3
could not be prevented or reversed by sn 100 Zn+2 , rather
4.0 x 10- 3 M and 10- 2 M Ai+3 caused a highly significant
0.001) decrease in the activity of the zn+ 2 activated
enzyme. Similarly, the Al+3 -induced inhibition of ALAD
was additive with that produced by rn 50 Pb +2 and no
concentration of Al+ 3 prevented or reversed the rn 50 Pb+ 2 (P

<

induced inhibition of ALAD.
Monovalent silver is a soft Lewis acid with the same
. Zn +2 , Cd+2 ,
d 10 valence electronic configuration found ~n
However, Ag+ (FIGURE 17), unlike zn+2 and Cd+2
and Hg+2
but like Hg+ 2 , was only found to inhibit ALAD in the concentration range studied. At concentrations of 2.0 x 10- 6 M
and greater Ag+ caused a highly significant (P

0.001)
decrease in ALAD activity, the rn 50 being 2.0 x 10- 6 M. Ag+
did not prevent or reverse the inhibition of rn
Pb +2 nor
50
could the Ag+-induced inhibition by prevented or reversed by
<

:I
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zn+Z
Rather, the Ag+-induced inhibition was additive
100
with the activation by zn+Z and the inhibition by Pb+Z in a
sn

highly significant (P

<

0.001) manner.

Trivalent gallium and indium also have d 10 valence
electronic configurations but, unlike the other d 10 ions
already discussed which are soft or borderline Lewis acids,
Ga+3 and In+3 are hard Lewis acids. Both Ga+ 3 and In+ 3
(FIGURE 18) caused a very significant (P

<

0.01) inhibition

of adult human erythrocytic ALAD activity at concentrations
of 4.0 x 10- 4 M and 10- 3 M, the In 50 for both being 7.0 x
10- 4 M. The inhibition produced by both Ga+ 3 and In+ 3 could
be prevented or reversed by sn 100 Zn+2 throughout the concentration range studied. Ga+ 3 and In+ 3 were, however, unable to prevent or reverse the inhibition of ALAD by ID 50
Pb+2 , the inhibition by both Ga+ 3 and In+ 3 actually caused
a very significant (P < 0.01) increase in the Pb+2 -induced
inhibition of erythrocytic ALAD.
The effects of the last metal ions studied, Sn+Z and

Sn +4 ' are illustrated in FIGURE 19.

The borderline Lewis

acid Sn+Z has the s 2 d 10 valence electronic configuration of
Pb+Z and, like Pb+2 , caused an inhibition of erythrocytic
ALAD at very low concentrations that could be prevented or
reversed by zn+ 2 . At concentrations of 10- 5 M and above
Sn+Z caused a highly significant (P
ALAD, the ID

0.001) inhibition of
for Sn+Z being 4.0 x 10- 5 M. The Sn+Z_
<

50
induced inhibition of ALAD could be completely prevented or
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reversed by

sn 100

Zn+2 up to 10 -3 I1 Sn+2 where a very

0.01) decrease in the activity of the zn+ 2
activated enzyme was observed. Sn+2 could not prevent or
reverse the rn 50 Pb+2 -induced inhibition but the inhibition
produced by Sn+2 at concentrations of 4.0 x 10-S M and
greater was additive with that produced by rn
Pb+ 2
The
50
hard Lewis acid Sn+4 has the same valence electronic configuration as Ag+, zn+ 2 , Cd+ 2 , Hg+ 2 , Ga+3 and In+ 3 . Sn+4
significant (P

<

caused a very significant (P < 0.01) inhibition of ALAD only
at a concentration of 4.0 x 10- 4 M and above and this inhibition was additive with the

sn 100

zn+2 stimulation.

At a con-

centration of 10- 4 M Sn+4 was able to cause a highly significant (P < 0.001) reversal of the rn 50 Pb+2 -induced inhibition but only to 67% of the uninhibited control ALAD
activity. At 10- 3 M the inhibition produced by Sn+2 caused
a very significant (P
caused by rn 50 Pb +2 .

<

0.01) increase in the inhibition
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D.

THE EFFECT OF PREINCUBATION ON THE ACTIVATION AND INHIBITION OF NORMAL ADULT HUMAN ERYTHROCYTIC ALAD BY METAL
IONS IN VITRO

In order to further investigate the interesting
effects of Pb+2 , Zn+2 , Cd+ 2 , ~nd Hg+2 on normal human erythrocytic ALAD, various concentrations of these cations were
added to hemolysates which were then incubated at 37°C for
1.0 hour before adding the substrate.

These results are

compared with the effect of these metal ions on normal adult
human erythrocytic ALAD activity when they were added to
hemolysates immediately prior to adding the substrate.

The

activity of control hemolysates incubated for 1.0 hour at
37°C before adding the substrate was not significantly
different than the activity of a nonpreincubated control
hemolysate.
FIGURE 20 illustrates the effect of various concentrations of Pb+2 and Hg+2 on normal adult human erythrocytic
ALAD when added without preincubation and before a 1.0 hour
preincubation of the hemolysate.

As indicated in this

figure, a 1.0 hour preincubation enhanced the inhibition of
erythrocytic ALAD by Pb+2 , causing a very significant (P <
0.01) decrease in the In 50 from 1.9 x 10- 6 M Pb+ 2 without
preincubation to 6.2 x 10- 7 M with a 1.0 hour preincubation.
A 1.0 hour preincubation of the whole blood hemolysate with
Hg+ 2 similarly enhanced the ability of Hg+ 2 to inhibit ALAD,
causing a very significant (P

<

0.01) decrease in the In

50
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for Hg +2 from 6.0 x 10- 6 M without preincubation to 1.9 x
10- 6 M with a 1.0 hour preincubation.
FIGURE 21 illustrates the effects of a 1.0 hour preincubation with the metal ion on the activation of erythrocytic ALAD by zn+ 2 and on the activation and inhibition by
Cd+2 .

A 1.0 hour preincubation with the hemolysate had no
significant effect whatsoever on the ability of Zn+ 2 to
activate erythrocytic ALAD.

the other hand, a 1.0 hour
preincubation of the enzyme with Cd+ 2 not only caused a
very significant (P < 0. 01) enhancement of the Cd+2·-induced
On

inhibition of ALAD, changing the rn 50 from a non-preincubation concentration of 8.0 x 10- 5 M to 2.5 x 10- 6 M with a
1.0 hour preincubation, but it also completely prevented the
Cd+ 2 activation of erythrocytic ALAD. The Cd+ 2 sn100 caused
a very significant (P < 0.01) activation of erythrocytic
ALAD to 124% of the control activity when added without
preincubation but caused a highly significant (P < 0.001)
decrease to 42% of the control activity when preincubated
with the enzyme for 1.0 hour.
Additional experiments were conducted in which various
concentrations of Pb+ 2 , Cd+ 2 , or Zn+ 2 were added to the hemolysates without preincubation or prior to preincubation for
0.5, 1.0, 2.0, and 4.0 hours at 37°C before adding the substrate.

The activities of control hemolysates preincubated

for 0. 5 or 1. 0 hour prior to adding the substrate -.;.Jere not
significantly less than the activity of a nonpreincubated
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control hemolysate but the activities of control hemolysates
preincubated for 2.0 or 4.0 hours were.
The enhancement of Pb+ 2 -induced inhibition previously
described for a 1.0 hour preincubation with Pb+2 is already
apparent after a 0.5 hour preincubation with Pb+ 2 and
becomes more marked with 2.0 and 4.0 hours of preincubation
(FIGURE 22).

That this is not due solely to denaturation of

the enzyme on preincubation is suggested by FIGURE 23 in
which the results of the preceeding figure are plotted as a
function of the preincubation time.

While the control

activity decreases after 2.0 and 4.0 hours of preincubation,
the inhibition induced by various concentrations of Pb+2
increases at a faster rate beginning at earlier preincubation times.
In a similar manner, the prevention of the activation
of ALAD by Cd+ 2 and the enhancement of Cd+ 2 -induced inhibition as a result of a 1.0 hour preincubation of the hemolysate with Cd+2 is notable after 0.5 hour of preincubation
with the· enzyme and is more marked after 2.0 and 4.0 hours
of preincubation (FIGURE 24).

Again, when these results

are represented as a function of the preincubation time
(FIGURE 25), it can be seen that this is apparently a true
preincubation phenomenon and not solely due to denaturation
of the enzyme as a result of the preincubation.
As can be seen in FIGURES 26 and 27, preincubation of
the hemolysate with zn+ 2 for 0.5, 1.0, 2.0, and 4.0 hours
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had little effect on the zn+2 activation of human erythrocytic ALAD.

This is in marked contrast to the effects of

preincubation on the effects of Pb+Z and Cd+Z on ALAD.
Further experiments were conducted to determine
whether the enhancement of Pb+2 -, Hg+Z
and Cd+ 2 -i~duced
inhibition and the prevention Cd+Z activation of ALAD
after preincubation with these cations is the result of
denaturation of the enzyme during preincubation, rendering
it more susceptible to inhibition, or a true preincubation
phenomenon.

In these experiments the effect of various concentrations of Pb+ 2 , zn+ 2 , Cd+2 , and Hg+Z on ALAD activity

was determined when these ions were added without preincubation, before a 1.0 hour preincubation, and after a 1.0 hour
preincubation (FIGURE 28).

It was found that there is

little, if any, difference between the results obtained when
the metal ions were added without a 1.0 hour preincubation
or after a 1.0 hour preincubation.

Similarly, the results

obtained when metal ions were added after a 1.0 hour preincubation were as significantly different from those obtained
when the metal ions were added prior to a 1.0 hour preincubation as the results obtained when the metal ions were
added without preincubation were.

It, therefore, seems
apparent that the enhancement of the Pb+ 2 -, Hg+ 2 -, and Cd+Z_
induced inhibition and, especially, the elimination of the
Cd+Z activation may indeed be the result of a true preincubation phenomenon and not of protein denaturation.
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The final consideration of the present research was to
determine whether or not preincubation would interfere with
the ability of Zn+ 2 to affect the reactivation of Pb+2
The ID 50 of Pb+ 2 determined under nonpreincubation conditions was added to the hemolysates after
inhibited ALAD.

preincubation for 1.0 hour with various concentrations of
.
.
.
Zn+2 . I n a dd.~t~on,
var~ous
concentrat~ons
o f Zn +2 were
added to hemolysates after preincubation for 1.0 hour with
the preincubation ID 50 Pb+ 2
Finally, the preincubation
In
Pb+2 and various concentrations of zn+2 were added to
50
the hemolysate prior to preincubation for 1.0 hour.
As can be seen in FIGURE 29, zn+ 2 is able to completely prevent or reverse the effect of a preincubation rn 50
Pb+2 whether zn+2 was added after a 1.0 hour preincubation
with Pb+2 or was preincubated simultaneously with Pb+2 . A
Zn~ concentration of 3.7 x 10 -4 M reversed the Pb ~ -induced
inhibition of ALAD to 132% of the uninhibited, nonpreincubated control activity when added after preincubation with
Pb+2 and to 137% of the control activity when preincubated
simultaneously with Pb+2 .
It will be noted in FIGURE 30 that preincubation with
zn+ 2 was able to completely prevent the inhibitory effects
of Pb+ 2 on ALAD whether the inhibition was caused by preincubation ID 50 Pb+2 or by nonpreincubation In 50 Pb+ 2
A concentration of 3.7 x 10- 4 M zn+ 2 reversed the Pb+ 2 -induced inhibition of ALAD to 140% of the uninhibited, nonpreincubated
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+2
control activity when Pb
was added after preincubation
+2
with Zn
and to 137% of the control activity when preincubated simultaneously with Pb+ 2 .

CHAPTER V
DISCUSSION

CHAPTER V
DISCUSSION
A.

THE IMPLICATIONS OF THE ASSOCIATION OF THE DECREASE IN
ERYTHROCYTIC ALAD ACTIVITY WITH THE DECREASE IN RETICULOCYTE PERCENT IN THE DEVELOPING }MLE ALBINO RAT
Because a decrease in erthrocytic ALAD activity is

often used as an index of the degree of lead intoxication,
the correlation of a decrease in the activity of erythrocytic ALAD with a decrease in the reticulocyte percent as the
normal male albino rat develops could be an important source
of variability in the analysis of the lead intoxication of
newborn and developing rats.

This should, therefore, be

carefully controlled for or the erythrocytic ALAD assay
should be completely avoided when evaluating the degree of
experimental lead intoxication of newborn and developing
male (and, presumably, female) albino rats.
The prolonged elevation of erythrocytic ALAD activity
and reticulocyte percent observed in the developing rat may
well reflect a prolonged net peripheral heme biosynthesis;
whether or not it actually does remains to be investigated.
In light of this possibility, a consideration of the age of
the animal might also be in order when using the newborn
and developing male albino rat as a model for other disorders of heme synthesis including the porphyrias.
119
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The association of a decrease in erythrocytic ALAD
activity with a decrease in the reticulocyte percent as the
male albino rat develops suggests that with the maturation
of the erythrocyte there is a gradual decline in the activity of the soluble cytoplasmic enzyme ALAD in addition to
the expected loss of the mitochondrial heme biosynthetic
enzymes.

While the association of a high ALAD activity with

a large population of young cells capable of synthesizing
protein suggests the loss of ALAD activity as the nonnucleated cell population ages is due to protein degradation
or to protein denaturation (due to such factors as oxidation
of -SH groups to

-s-s-

bonds or to dissociation of the

enzyme subunits) it certainly does not prove it.

The de-

cline in erythrocytic ALAD activity with a decrease in the
reticulocyte percent and an increase in the age of the animal may reflect an increased body burden of the ubiquitous
environmental contaminant and ALAD inhibitor Pb+Z as the
animal ages.

The decrease in the ALAD activity with a de-

crease in the reticulocyte percent and increase in the.age
of the animal may also reflect a difference in the content
or metabolism of a cofactor of ALAD (such as zn+ 2 -see below)
in the young versus the old cells or to a difference in the
serum levels or whole animal metabolism of such a cofactor
at various stages of development.

Such possibilities could

be explored in this animal model and could possibly provide
some insights into one of the basic processes of ageing-the
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alteration of enzymes (Rothstein, 1975).

This model could

be especially useful for the study of the alteration of
enzymes on ageing since the role of sequence changes during
protein synthesis in this process could be more easily controlled for than in other model systems in which the cells
are nucleated.
Abdulla et al. (1978a) have recently confirmed the
observation of a very high erythrocytic ALAD activity in
rats after partus and of a marked decrease in the activity
of the enzyme during the early growth period of the rat.
While these investigators could not measure plasma and
whole blood zn+Z concentrations in young animals, they did
find that animals less than six weeks old when fed a zinc
deficient diet had a significantly lower ALAD activity than
those animals fed a diet containing adequate levels of zinc.
In older animals, on the other hand, the level of dietary
zinc had no effect on erythrocytic ALAD activity.

In

addition, since hepatic zinc plays an active role in zinc
homeostasis (Abdulla et al., 1978b) and hemoglobin synthesis during fetal and early developmental growth in the rat
occurs in the liver, these investigators examined the zinc
status of the liver and found that the livers of newborn
rats had zinc levels three times higher than those of adult
rats.

This, together with the finding that in zinc defi-

ciency the hepatic zinc levels were also decreased, may
offer some explanation of the differences in ALAD activity
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as the animal develops.

More work certainly remains to be

done to further investigate this.
In the same article Abdulla and associates also reported the observation that the erythrocytic ALAD activity
of human infants is nearly one and one-half times that of
the adult human. Plasma zn+2 concentrations of the newborn
are 25% higher than those of the adult while whole blood
Zn+2 levels are 50% lower than those of the adult. This is
consistent with the earlier observation (Haeger-Aronsen et
al., 1976) that erythrocytic ALAD activity could be strongly
correlated with plasma Zn+2 levels and more weakly correlated with erythrocyte zn+2 levels.

However, this also raises

an interesting question needing further clarification because the plasma zn+ 2 levels reported by these investigators
for adult rats is significantly higher than that reported
for the adult human yet the adult rat has a much lower
erythrocytic ALAD activity than has the adult human.
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B.

THE POSSIBILE EXPLANATIONS FOR THE GENDER-RELATED DIFFERENCE IN NORMAL ADULT HUMAN ERYTHROCYTIC ALAD ACTIVITY
The biological significance of the gender-related dif-

ference in normal adult human erythrocytic ALAD activity is
minimal on the basis of the present information since it has
been suggested that there is excess enzyme in the body
(Lauwerys et al., 1974) and, more importantly, because the
mature erythrocyte does not synthesize heme.

However, this

sex-related difference could reflect higher absolute levels
of the enzyme in the erythroid precursors and the other
cells of the body, possibly as a reflection of a higher rate
of porphyrin synthesis in the female.

The gender-related

difference in erythrocytic ALAD activity could also be a
reflection of higher plasma or whole blood concentrations
or differences in the metabolism of a cofactor of ALAD (such
as zn+ 2 or Cu+-see below) or a lower concentration of an
inhibitor of ALAD (such as Pb+ 2 ).
The possibility that the sex-related difference in
erythrocytic ALAD activity is due to a sex-related difference in the blood lead level is unlikely since it has been
found, after an exhaustive international study, that the
blood level of normal adult males is not significantly
different than that of the normal adult females (Goldwater
and Hoover, 1967).

Similarly, the possibility that this

difference is due to a sex-related difference in the levels
of zinc, a possible activator of ALAD, is unlikely since it
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has been reported that there are no gender-related differences in whole blood, erythrocytic, or plasma zinc levels
(Vallee and Gibson, 1948; Halsted and Smith, 1970).

A

possible explanation of the sex-related difference in erythrocytic ALAD activity that merits further consideration is
the fact that female serum copper levels are significantly
higher than male serum copper levels (Lahey et al., 1953;
Bloomfield and MacMahon, 1969); this relationship is particularly interesting in light of the possibility, discussed
below, that Cu+ is the true in vivo activator of ALAD.
Until further research explains the reason for the
difference between the mean male and female erythrocytic
ALAD activities, this sex-related difference should be considered when establishing reference values for the erythrocytic ALAD assay used as a diagnostic aid in the evaluation
of lead intoxication.
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C.

THE CONSIDERATIONS REGARDING THE EFFECT OF HETAL IONS ON
NORMAL ADULT HUMAN ERYTHROCYTIC ALAD ACTIVITY IN VITRO

1. THE GENERAL CONCLUSIONS CONCERNING THE PHYSICAL AND CHEHICAL PROPERTIES ASSOCIATED WITH THE ABILITY OF HETAL IONS
TO ACTIVATE OR INHIBIT HID1AN ERYTHROCYTIC ALAD IN VITRO
The findings of the present study that low concentrations of Cu+2 , Ag+ , Hg+2 , Sn+2 , and Pb +2 inhibit normal
adult human erythrocytic ALAD in vitro at very low concentrations is entirely consistent with the reports of others
(Calissano et al., 1965; Tomio et al., 1968; Chiba and
Kikuchi, 1978) and is not surprising in light of the sulfhy.
.
.
o f h uman eryt h rocytLc
dry 1 nature o f ALAD . Zn + 2 actLvatLon
ALAD is also consistent with the reports of others of the
Zn+2 activation of ALAD from human and other mammalian
sources (Abdulla and Haeger-Aronsen, 1971; Cheh and Neilands,
1973; Finelli et al., 1974) as is the prevention or reversal
of Pb+ 2 -induced inhibition of ALAD by zn+2 (Finelli et al.,
1975).

Ind~ed,

recent reports have confirmed the observa-

tion of zn+2 activation of ALAD (Mitchell et al., 1977) as
well as the protective effect of zn+2 against Pb+ 2 -induced
inhibition of ALAD (Border et al., 1976b, Haeger-Aronsen, et
al. , 1976; Cantrell et al. , 1977).
Normal human whole blood concentrations of zinc are
1.35 + 0.31 x 10- 4 M (Vallee and Gibson, 1948) which
corresponds favorably with the in vitro concentrations of
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zinc used in the present study.

Normal whole blood concentrations of lead are 0.7-1.9 x 10- 6 M (Goldwater and Hoover,

1967) which are also within the range of the in vitro concentrations of lead used in the present study; indeed, lead
has been reported to inhibit human erythrocytic ALAD in vivo
at whole blood concentrations much lower than the supposedly
safe upper limit of normal (Hernberg et al., 1970).

In

addition, evidence of clinical lead toxicity can be observed
at whole blood lead concentrations above 2.8 x 10- 6 M
(Gibson et al., 1968).
The suggestion that the in vitro addition of Cd+ 2 can
stimulate ALAD activity (Wilson et al., 1972; Cheh and
Neilands, 1973; Ramp and Kriebitzsch, 1975) was unequivocally demonstrated in the present study and was later confirmed
(Mitchell et al., 1977). That Cd+2 is able to prevent or
reverse Pb+2 -induced inhibition of ALAD is a unique finding
of the present investigation.

Preincubation studies in the

present work, however, give reason to doubt the possibility
that activation of ALAD by Cd+2 might be observed in vivo
since prolonged exposure of the enzyme to Cd+ 2 causes enzyme
inhibition.
While the activation of ALAD by 0.18 mM zn+ 2 reported
by Meredith and associates (1974) was exactly duplicated in
this study their often cited observation of Al+J activation
of ALAD was not.

This discrepancy might be explained by

their use of a potassium phosphate buffer in their assay and
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is not unexpected in light of the hard Lewis acid character
of Al +3 and the presence of many soft Lewis base sites, the
sulfhydryl groups, on the enzyme.
The reported activation of human erythrocytic ALAD by
Mn+ 2 (Collier, 1971) could not be reproduced in the present
investigation. That the hard Lewis acid lm+2 has no effect
on ALAD except at very high concentrations was recently
confirmed (Hitchell et al., 1977).
The report by Hitchell et al. (1977) of the activation
of ALAD by 10-S H Hg+2 is inconsistent with the already
mentioned reports of others of inhibition of ALAD by Hg+ 2
at these concentrations and could not be reproduced in the
present study.

TI!e findings of Mitchell and co-workers is

contrary to what is expected on the basis of the properties
of Hg+2 for, while Hg +2 has the same valence electronic con. v~tro
.
.
h
.
.
f ~gurat~on
as Cd+2 an d Zn +2 , ~n
act~vators or eryt rocytic ALAD, its chemical properties are quite different than
other members of Group IIB of the Periodic Table, as
discussed below.
The metal ions Na+, Hg+2

Ga +3 , I n +3 , and Sn+4 were

not found to have any significant effect on human erythrocytic ALAD activity except at very high concentrations and
there is no report in the present literature of any significant effect of these metal ions on the ALAD from any other
mammalian source.
TABLE 2 lists the physical and chemical properties of

f
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metal ions generally considered of importance in the interaction of metal ions with proteins for each of the 14 metal
ions investigated in the present study.

These properties

include oxidation state, valence electronic configuration,
characteristic coordination number, coordination geometry,
and Pearson HSAB classification of Lewis acids.
T~~LE

In addition,

2 summarizes the effects of these metal ions on eryth-

rocytic ALAD by listing the ID 50 and the sn
. Several
100
important conclusions concerning the physical and chemical
properties associated with the ability of a metal ion to
activate or inhibit erythrocytic ALAD in vitro can be
reached on the basis of the above results.
On

the basis of the present study it can be concluded

that hard acids have no effect on erythrocytic ALAD in vitro
except at concentrations approaching the millimolar range,
very high concentration for a metal-protein interaction.
Thus even those hard acids with the same valence electronic
.
.
con f ~gurat~ons
as Zn + 2 an d Cd+2 ("~.e. Ga + 3 , I n + 3 , and Sn+4 )
or with the same oxidation state as Zn+ 2 and Cd+2 (i.e. Mg+2
and 1~+ 2 ) were found to be without effect on erythrocytic
ALAD except at very high concentrations.

This implies that

activation and inhibition of ALAD is due to the interaction
of the metal ions with a soft Lewis base of the enzyme, such
as the sulfhydryl group, rather than with a hard Lewis base.
The present evidence indicates that borderline or
soft Lewis acids having a planar coordination geometry and

II•
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either a characteristic coordination number that does not
give the ion the electronic configuration of a noble gas,
hence have empty £ orbitals into which electrons can be
donated by a ligand in a

~

bond, or a characteristic coor-

dination number that gives the ion the electronic configuration of a noble gas and a geometry that permits donation of
~

electrons to a ligand in a

~

bond which reduces the

negative charge on the central ion, inhibit ALAD at very
low concentrations.

Thus, despite having the same valence

.
electronic configuration as Zn~ and Cd~ , the soft Lew~s
'd s A+
. h a c h aracter~st~c
. . coer d'~nat~on
.
ac~
g an d Hg+ 2 , w~t
number of 2 (which will not give them the electronic configuration of a noble gas that a coordination number of 4
would) and a linear coordination geometry, inhibit erythrocytic ALAD. Similarly, the borderline Lewis acids Sn+ 2 and
Pb+2 , despite having the same oxidation state as zn+ 2 and
Cd+2 , have a planar coordination geometry (~-tetrahedral)
which permits the donation of

~

electrons to ligands in a

coordinate bond and inhibit the enzyme.

~

These Lewis acids

could, therefore, form not only a a coordinate-covalent
bond with a soft Lewis base of the enzyme, such as the
sulfhydryl group, but also a much more stable bond by

~

bond

formation through either accepting electrons from sulfur
into empty£ orbitals (i.e. Ag+ and Hg+ 2 ) or donating
electrons into an empty ~orbital of sulfur (i.e. Sn'+2 and
Pb +2 ), thereby inhibiting the enzyme.
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Of the 14 metal ions studied, only the borderline
Lewis acid zn+2 and the soft Lewis acid Cd+ 2 activate erythrocytic ALAD in vitro and prevent or reverse the in vitro
Pb+ 2 -induced inhibition of erythrocytic ALAD. These are
. 1 ent, dlO Lew~s
.
d ~va

"d s

ac~

. h a ch aracter~st~c
. . coor d"~nat~on
.

w~t

number of 4 that gives them the electronic configuration of
a noble gas and a nonplanar coordination geometry (tetrahedral). Thus both zn+ 2 and Cd+2 are able to readily form
only a cr coordinate covalent bond with a soft Lewis base of
the enzyme, such as the sulfhydryl group.
Because all of the metal ions affecting the activity
of normal adult human erythrocytic ALAD are borderline or
soft Lewis acids it seems reasonable to assume that they are
all acting at the same soft Lewis base site of the enzyme
with activation or inhibition of the enzyme depending on
the relative strengths of the coordination bond formed.

The

fact that the -SH group, a soft Lewis base, is the most
active group found in cells, with coordinate covalent bonding leading to metal mercaptide formation being among the
most specific of its reactions (Boyer, 1959), together with
the fact that ALAD contains a very large number of -SH
groups (Wilson et al., 1972; Shemin, 1972; Tsukamoto et al.,
1975; Shemin, 1976) strongly suggests that the soft Lewis
base with which these metal ions interact is the -SH group.
In addition, the sulfur atom of the -SH group has both empty
~

orbitals that can accept electron pairs from a central ion
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and unshared pairs of electrons that can be donated to a
central ion in the formation of rr coordinate bonds which
would, in either case, be strong enough to account for inhibition of the enzyme by metal ions.
Both zn+2 and Cd+2 are able to prevent or reverse the
in vitro inhibition of ALAD induced by the borderline Lewis
acid Pb+2 . zn+2 is also able to prevent or reverse the in
vitro inhibition of ALAD induced by the borderline Lewis
acid Sn+2 but not that induced by the soft Lewis acids Ag+
and Hg+ 2

These results are easily explained if all six

ions compete for the same binding sites on the enzyme. The
borderline acid-soft base bond formed by Pb +2 an4 Sn+2 with
the enzyme appears to be strong enough to inhibit the enzyme
but weak enough (perhaps due to

TI

bond formation by donation

of the electron pairs of the metal ions to the empty d
orbitals of the sulfide) to permit exchange with sufficiently high concentrations of zn+2 or Cd+ 2 . The soft acid-soft
base bond formed by Ag+ and Hg+2 with the enzyme appears to
be strong enough to not only inhibit the enzyme but also
(perhaps due to

TI

bond formation by donation of the electron

pair of sulfur to the empty £ orbitals of the metal ions) to
prevent exchange with zn+2 no matter how high the concentration. Thus Pb+2 and Sn+2 may exchange readily with Zn+2 and
Cd+ 2 but Ag+ and Hg+ 2 may no t exc h ange wL"th Zn + 2 b ecause

TI

I''I

bonds that do not contribute to completing a noble gas electronic configuration are more readily broken than those that

I
I
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do.
The unique ability of zn+ 2 to both activate ALAD in
.
. v1tro
.
Pb+ 2 -1n
. duce d
v1tro
an d to prevent or reverse t h e 1n
inhibition of ALAD even after a 1.0 hour preincubation with
the enzyme emphasizes the importance of not only the divalent, d 10 characteristics with a characteristic coordination
number that gives the metal ion a noble gas electronic configuration and a nonplanar coordination geometry but also
the borderline Lewis acid characteristics of a metal ion
activator of ALAD. The failure of Cd+2 to activate ALAD
in vitro after even a 0.5 hour preincubation with the enzyme
. b.1 1'1ty o f zn +2 to prevent or reverse t h e
as we 11 as t h e 1na
Cd+ 2 -induced inhibition of ALAD is most likely related to
the soft Lewis acid characteristics of Cd+ 2 since its other

important properties are the same as those of zn+ 2 .

It is
possible that on preincubation the kinetics of the Cd+ 2 enzyme interaction permit Cd+2 to assume a 6 coordinate
octahedral geometry which allows the soft acid-soft base
bond formed between Cd+ 2 and the enzyme to be strengthened
(due to rr bond formation by donation of the electron pair of
sulfur to an empty orbital of Cd+2 ), resulting in enzyme
inhibition.

Thus, of all the metal ions studied, the metal

ion most likely to function as an in vivo activator of
normal adult human erythrocytic ALAD and to serve as a
possible prophylactic and therapeutic agent in the preven.
t 1on

.
.
.
or treatment o f 1 ea d po1son1ng
1s

zn +2 .
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If zn+2 is indeed the in vivo activator of ALAD, the
inhibition of ALAD by Pb+ 2 may be a result of Pb+2 replacing
Zn+2 at its binding sites on the enzyme. This, together
with the fact that ALAD loses most, if not all, of its metal
2
ions on purification, would strongly suggest that Zn+
activated ALAD is a metal-enzyme complex and not a metalloenzyme. In order to confirm whether or not ALAD is a zn+2
metal-enzyme complex, the stability constant for the binding
of Zn+2 to the enzyme must be determined~

2.

A CONSIDERATION OF THE EFFECT OF COPPER ON ALAD

All of the metal ions in the present study, with the
exceptions of Cu+ 2 , have the stable electronic configurations of a noble gas or one in which the subshells are
either filled or half filled. The usual stable electronic
·
of Cu + 2 , 3d
· attr~'b utabl e to t h e f act t h at
.
con f ~gurat~on
_ 9 , ~s
the energies of the

3~

and

4~

orbitals in neutral atoms of

the first transition series are quite similar but the d
orbitals become stabilized relative to the s orbitals when
atoms have an oxidation state of 2 or more.

Therefore,

among the elements of the first transition series, the +1
oxidation state is rare regardless of its electronic configuration.

Copper is unusual even in this respect because the
Cu+ state is important due to its stable, d 10 , electronic

configuration. However, at least in aqueous systems, the
cu+ 2 state is the dominant ionic form because of the greater
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lattice and solvation energies and formation constants for ·
its complexes (Cotton and '.Jilkinson, 1972).
The borderline Lewis acid Cu+2 has a square planar
coordination geometry so, as expected on the basis of the
results obtained for Pb+2 , Sn+2 , Ag+ and Hg+ 2 , it inhibits
erythrocytic ALAD at very low concentrations. Having both
a 3d 9 valence electronic configuration with its single unpaired electron and a characteristic coordination number of
4, Cu+ 2 is unable to achieve the electronic configuration of
a noble gas through cr coordinate bond formation or through
accepting electrons into empty E. orbitals in the formation
of a ~ coordinate bond. Cu+2 can, however, donate d orbital
electrons to the ligand causing inhibition of ALAD that can
be prevented or reversed by zn+2 . Thus the inhibition of
ALAD by Cu+ 2 and its reversal by zn+2 appear to be very
similar to that of both Pb+ 2 and Sn+2 .
Of all the metal ions not investigated in the present
study, the only other ion that could possibly function as a
metal ion activator of ALAD on the basis of the observations
of this study is Cu+ . Cu+ is a soft Lewis base with the
same d 10 valence electronic configuration, characteristic
coordination number of 4, and tetrahedral coordination
geometry as Zn+2 and Cd+2
The soft Lewis base nature of
Cu+ together with its ready oxidation to the powerful ALAD
inhibitor Cu+ 2 , however, make this unlikely·. On the other
hand, cupric copper reacts with mercaptides to give cuprous
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copper and disulfide in a reversible reaction that proceeds
to the right if the cuprous ion is stabilized by complexation with suitable ligands, the strongest of which is RS
in the absence of air (Kalthoff and Stricks, 1951; Klotz et
al., 1958;

Hemmerich, 1966):
2Cu+ 2 + 4RS- ¢

RSSR + CuSR.

Reduced thiols have been reported to be necessary for the
maximum activity of erythrocytic ALAD, especially after
purification of the enzyme, presumably in order to reduce
oxidized sulfhydryl groups.

However, the possibility exists

that the enzyme loses activity due to air oxidation of the
essential enzyme activator Cu+ .to the inhibitor Cu+2 during
the process of purification of ALAD and the in vitro
analysis of the enzyme activity and reduced thiols are
necessary for maximum activity because they reduce Cu+ 2 to
Cu+ .

Reduced glutathione may be necessary for the maintain-

ance of in vivo ALAD activity (Moore et al., 1971) for the
same reason, maintaining the essential enzyme activator of
ALAD, copper, in ·its reduced form, Cu+, because the oxidized
· h"b.
Lea d cou ld , t h ere f ore,
f orm, Cu + 2 , ~n
~ ~ts the enzyme.
inhibit ALAD by reducing GSH concentrations, which it is
known to do (Shiraishi, 1952; Rubino et al., 1963; Batolska
and Marinova, 1970), as a result of which Cu+ remains oxidized as cu+2 which inhibits the enzyme. The activity of
the "lead inhibited" enzyme could then be restored by zn+2
because it replaces Cu+ with which it is isoelectronic.
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These suggestions would explain why copper was the only
metal ion found in stoichiometric amounts in beef liver
ALAD by Iodice et al. (1958) and why there was a good
correlation between ALAD activity and the copper content of
the enzyme

from~·

sphaerogena (Komai and Neilands, 1968).
The absolute requirement of ALAD for Cu+ 2 would be

very difficult to demonstrate in light of the fact that Cu+
immediately disproportionates to Cu+2 and elemental copper
upon ionization of its soluble salts in water (Cotton and
Wilkinson, 1972).

Cuprous acetonitrile perchlorate,

Cu(CH 3 CN) 4 clo 4 , prepared according to the method of Hemmerich and Sigwert (1963) as modified by Lonti et al. (1965),
is stable toward hydrolysis in the presence of excess
acetonitrile (1. 0 H), provided the critical pH of 6 has
not been exceeded, and could be used in an initial study of
Indeed, Cu(CH CN) Cl0 has been
3
4
4
used to reconstitute several Cu+-containing proteins includCu+ activation of ALAD.

ing haemocyanin (Lonti et al., 1965) and cytochrome c oxidase (Nair and Hason, 1967).

However, its use in studying

ALAD may present certain difficulties such as the low pH
and the very high concentrations of the organic solvent
i

acetonitrile that must be maintained, especially in light of

I,

the fact that very much smaller concentrations of another
organic solvent, ethanol, inhibit ALAD (Moore et al., 1971).
These difficulties will have to be carefully considered and,
hopefully, somehow circumvented.

I

I'
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3.

THE IN VIVO INVESTIGATION OF THE EFFICACY OF ZINC AS A
PROPHYLACTIC OR THERAPEUTIC AGENT IN LEAD POISONING
In 1972 Willoughby and associates reported the results

of a study in which groups of young growing horses were fed
an alfalfa-grass hay mixture plus increasing amounts of a
basal ration.

The basal ration was either a control diet
(containing 4.0 ppm Pb+2 and 180 ppm zn+ 2 ), a diet containing toxic amounts of Pb+ 2 only (800 ppm Pb+2 as PbC0 and
3
2
170 ppm zn+ ), a diet containing toxic amounts of zn+ 2 only
(18 ppm Pb+2 and 5400 ppm zn+ 2 as ZnO), or a diet containing

the same toxic amounts of both Pb+2 and zn+2 as the diets
containing only toxic amounts of Pb+ 2 or zn+ 2 over a 23 to
They found that toxic amounts of zn+2 interfere with the uptake of Pb+2 in areas of active bone formation and result in higher hepatic and renal Pb+ 2 without

38 week period.

these high levels being associated w·ith or causing impaired
neurologic function. Therefore, toxic amounts of zn+ 2
appeared to prevent the development of pharyngeal and
laryngeal paralysis, clinical signs of lead poisoning in the
young growing horse, but the exact mechanism was unknown.
In another study Thawley et al. (1977) fed rats lead
(0.5%), zinc (0.63%), cadmium (90 ppm), and a control diet
alone and in combination for 42 days with two levels of calcium (0.1 and 0.9%) and three levels of vitamin D (0, 2000.
and 50,000 IU/kg of feed).

They noted a reduction in uri-

nary ALA excretion and lowered blood and tissue lead levels
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in lead fed rats that were also fed excess zinc.

A reduc-

tion in urinary ALA excretion was also observed in lead fed
rats fed excess cadmium in a low vitamin D diet.

These

authors, however, were unable to determine whether the mechanism for the antagonism of the toxic effects of lead by
zinc was at the level of gastrointestinal absorption or at
the level of metabolic interference within the hemopoietic
system.
Thawley and co-workers (1978) also conducted a study
in which groups of rats were fed a control diet, a diet containing 0.6% zinc, and a diet containing 0.5% lead and 0.6%
zinc for six weeks.

Two additional groups of rats were used,

one group receiving the basal diet and intraperitoneal injections of 0.25 ml of a 20% ZnO suspension on the first,
fourteenth, and twenty-eighth days of the six week experimental period and the others receiving a diet containing
0.5% lead and the same intraperitoneal injections of a 20%
ZnO suspension.

They found that the oral or intraperitoneal

administration of zinc resulted in the reduction of urinary
ALA excretion in lead intoxicated rats to nearly normal
levels without any significant reduction in blood lead
levels or any alleviation of the anemia of lead poisoning.
This led these investigators to conclude that the effect of
zinc is at a physiologic level beyond gastrointestinal absorption, presumably reactivating ALAD inhibited by lead or
preventing inhibition of ALAD by lead.

These investigators
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. .
.
. . f.1.cant
also f oun d t h at Pb + 2 a dm1.n1.strat1.on
cause d a s1.gn1.
decrease in blood zn+ 2 levels.
Haeger-Aronsen and associates (1976) recently investigated the effect of lead (as lead acetate), zinc (as zinc
sulfate), and lead and zinc together in the rabbit when
injected subcutaneously on the back. One group of animals
received 63 mg zn+2 ;kg on day 0 and 200 mg zn+2 /kg on day 28;
another group of rabbits received 18 mg Pb+2 /kg on day 0 and
50 mg zn+2 ;kg on day 28; a third group of rabbits received
25 mg Pb+ 2 ;kg on day 0 while the fourth group received 25
mg Pb+2 ;kg on day 0 and 200 mg zn+2 ;kg on day 35. They
found that zinc has a strong activating effect on ALAD in
vivo, nearly eliminating the inhibitory effect of lead.
In 1976 Cerklewski and Forbes reported the results of
an investigation of the influence of dietary zinc on the
toxicity of dietary lead in the young male rat.

Nine groups

of rats were fed a semipurified diet containing 8, 35, or
200 ppm zinc (as zinc carbonate) alone or in combination
with 0, 50, or 200 ppm lead (as lead acetate) over a seven
week period.

They found that as dietary zinc was increased

the severity of lead toxicity decreased.

The evidence for

this decrease in lead toxicity was: a decreased concentration of lead in blood, liver, kidneys, and tibias; a decreased excretion of urinary ALA; a decreased accumulation
of FEP; a decreased inhibition of kidney ALAD.

In a second

experiment they investigated the effect of zinc injected
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intraperitoneally (as zinc sulfate) on the toxicity of
dietary lead and found it afforded no protection.

They

therefore concluded that the protective effect of zinc
against lead toxicity is primarily the result of an inhibition of the intestinal absorption of lead.
In a similar study Cerklewski and Forbes (1977)
examined the effect of dietary copper on the toxicity of
dietary lead in the young male rat.

Six groups of rats

were fed a semipurified diet containing 1, 5, or 20 ppm
copper (as cupric chloride) alone or in combination with 0
or 200 ppm lead (as lead acetate) over a four week period.
They found that as dietary copper increased so did the
severity of the lead toxicity.

The evidence for the in-

creased lead toxicity was an increased lead concentration in
the kidney and a two- to threefold increase in the excretion
of urinary ALA.

These investigators hypothesize that the

increasing dietary copper concentration may have a modifying
effect on other trace elements (such as zinc), producing
more favorable conditions for the development of lead
toxicity.
A recent article (Thomasina et al., 1977) reports the
interesting case of a lead intoxicated 37 year old male with
an extremely high blood lead level (260

~g/100

ml of whole

blood) studied before and after treatment with Na 2 (Ca-EDTA)
and then before and after oral administration of zinc sulfate.

Immediately after 5 days of daily parenteral doses
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of 500 mg Na 2 (ca-EDTA) the blood lead level was 100 ~g/
100 ml of whole blood and continued to fall until, at 49
days after the onset of chelation therapy, it was 55
100 ml of whole blood.
146 to 68

~g/100

~g/

Serum zinc concentrations fell from

ml during chelation therapy while 24 hour

urinary zinc excretion rose dramatically, reaching a peak
of nearly 7000

~g/24

hours during the last day of therapy

which was nearly five times higher than the highest prechelation value. During chelation therapy more than 27,281 ~g
of zn+2 was excreted which was nearly four times more than
the 7700 ~g of Pb+2 excreted.

Erythrocytic ALAD activity

was 20% of the control value prior to chelation therapy,
declined to 12.2% of control during chelation, and rose to
25.5% of control on the day after chelation was discontinued.
Thirty-six days after chelation therapy ended 100

~g

of zinc

sulfate was administered orally to the patient three times a
day for five days.

The zinc sulfate therapy had little

.
effect on the serum Zn~ , blood Pb ~ , ur~nary
Zn~ , or
.
Pb+2 concentrat~ons.
.
ur~nary
There was, however, a significant increase in erythrocytic ALAD activity to 35% of the
control value as a result of the Zn+2 therapy. On the basis
of these results the authors concluded that Zn+2 may play a
.

protect~ve

. 1 ea d
ro 1 e ~n

. .

tox~c~ty

.
an d zn + 2 supp 1 ementat~on

may be a useful adjunct to chelation therapy for lead
toxicity.

Unfortunately these results are not as clear

cut as they might have been since the biggest decrease (50%)
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in both blood lead and serum zinc were observed as a result
of eight days of hospitalization prior to the onset of chelation therapy.

The decreased blood lead is most likely due

to a discontinuation of exposure to the environment of the
lead battery factory where the subject was employed while
the decreased serum zinc may be due to a discontinuation
of exposure to the several pints of whiskey he consumed
daily for several years.
Nonet h e 1 ess, t h e

.

suggest~on

.
t h at zJn+ 2 supp 1 ementat~on

may be useful adjunct to chelation therapy for lead
toxicity or a useful prophylactic agent for preventing lead
toxicity seems reasonable.

The reasons for this bear

reviewing:
a. Pb+ 2 inhibits erythrocytic ALAD
b. Pb+2 causes a significant decrease in the serum
zn+ 2 concentration
c. Na 2 (Ca-EDTA) therapy results in a marked increase
. t h e ur~nary
.
.
~n
excret~on
o f zn +2 an d a correspon d ing fall in serum zn+ 2 levels
.
. a mark e d decrease ~n
.
d . Zn + 2 d e f.~c~ency
resu1 ts ~n
erythrocytic ALAD activity
e. inhibition of ALAD contributes significantly to
the anemia of lead poisoning
f. inhibition of ALAD results in a dramatic accumulation of the substrate ALA in the serum and various
organs
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g. the increased levels of ALA may be responsible
for some of the neurologic, gastrointestinal, and
cardiovascular symptoms of lead poisoning
h. zn+Z activates and prevents or reverses Pb+Z_
induced inhibition of erythrocytic ALAD in vitro
i. toxic levels of zn+Z prevent or reverse the toxic
effects of Pb+Z in vivo at the level of gastrointestinal absorption, at the level of interference
with the hemopoietic system, or at both levels
j. zn+Z can be administered in very large doses without toxic effects (National Research Council Subcormnittee on Zinc, 1979).
Before zn+Z supplementation is used as a prophylactic agent
or therapeutic adjunct in the prevention or treatment of
lead poisoning it is desirable to understand whether zn+2
primarily prevents the gastrointestinal absorption of Pb+Z
or prevents or reverses the Pb+2 -induced inhibition of ALAD
so a protocol for zn+Z supplementation can be established
for each use.
In determining the site of zn+Z interference with lead
toxicity a most important consideration is the choice of an
animal model.

While no single species is an exact model for

the effect of lead in man, the rabbit is among the few animals in which lead poisoning interferes with porphyrin metabolism as it does in man (Hass et al., 1964; Scharding and
Oehme, 1973) and the location and sequence of the development

144
of renal pathology resemble those of man (Hass et al., 1964;
Macadam, 1969; Scharding and Oehme, 1973).

In addition,

the activity of rabbit erythrocytic ALAD is one of the few
erythrocytic ALAD activities that is at least as high as
that of man (Abdulla et al., 1978a).

The rabbit, therefore,

seems to be a logical choice as an animal model for this
study.
In order to evaluate the efficacy of Zn+2 as a prophylactic agent for the prevention of lead poisoning or as
a therapeutic agent for the treatment of lead poisoning the
following protocol is proposed and could be modified as the
need arose.

Fifty-six young adult male New Zealand white

rabbits should be divided into seven groups of eight and
fed a control diet, a control diet supplemented with zinc
acetate, a control diet supplemented with lead acetate, or
a control diet supplemented with both Pb+ 2 and zn+ 2 . The
daily lead dose should be chosen because it is sublethal
and the zn+ 2 dose should be chosen so as to provide a molar
concentration of zn+2 that is equal to or twice the molar
concentration of the sublethal dose of lead but is itself
subtoxic.

The seven groups could be:

a. animals fed a control diet
+2
b. animals fed 20 mg Pb /kg/day in a control diet
for 24 weeks
c. animals fed 6.3 mg Zn+2 /kg/day in a control diet
for 24 weeks
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d.

.

an~mals

fed 20 mg Pb +2 /kg/day and 6.3 mg Zn+2 I

kg/day in a control diet for 24 weeks
e. animals fed 20 mg Pb+ 2 /kg/day in a control diet
for the first 12 weeks and a control diet for
the last 12 weeks
f. animals fed a control diet for the first 12 weeks
and 6.3 mg zn+2 /kg/day in a control diet for the
last 12 weeks
g. animals fed 20 mg Pb+ 2 /kg/day in a control diet
for the first 12 weeks and 6.3 mg Zn+2 ;kg/day in
a control diet for the last 12 weeks
At the end of the experimental period the animals
should be weighed and 24 hour urines collected.

The animals

can then be sacrificed, blood collected in the appropriate
Vacutainer tubes, and the following determined on the blood
and urine:
a. 24 hour urinary output
b. serum and urinary creatinine
c. complete blood count
d. reticulocyte percent
e. erythrocytic ALAD activity, unactivated by zn+2
and activated by zn+2 so the ratio can be
determined
f. serum and urinary ALA
g. whole blood and urinary lead
h. serum and urinary zinc
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i. serum copper
j. serum iron
(It is necessary to determine serum copper because zinc is
reported to act as a copper antagonist (Hill, 1976) and
serum iron in order to rule out iron deficiency anemia.)
Upon analyzing these results using an analysis of variance
one should be able to determine at which site zn+2 antagonizes the toxic effects of Pb+2 .
In addition to the above measurements at the end of
the above experiment it might be interesting to do some
histology on at least the kidney and perhaps also the liver
and bone marrow in order to determine whether or not zn+ 2
prevented any lead-induced change in their histology.
Once it has been determined at which site or sites
zn+2 is acting, its efficacy as a prophylactic agent or
therapeutic adjunct should be apparent. If zn+ 2 is indeed
potentially valuable as a therapeutic adjunct, further
studies can be conducted in order to determine the proper
doses of zn+2 to be used in conjunction with Na 2 (ca-EDTA)
and the times at which the doses should be administered with
respect to the times of administration of the chelating
agent. If zn+2 is indeed potentially valuable as a prophylactic agent, further studies can be conducted in order
to determine the proper doses of zn+ 2 to be used for the
various routes and levels of lead exposure.

CHAPTER VI
Sill1MARY

CHAPTER VI
SUMMARY

A correlation between blood reticulocyte percent and
the activity of erythrocytic ALAD in the developing rat has
been established during the progression from a state of
macrocytic hypochromic anemia at birth to a normocytic
normochromic state at puberty and, finally, to a state just
prior to adulthood at which the reticulocyte percent had
stabilized.

Both reticulocyte percent and erythrocytic

ALAD activity were found to decrease with age, rapidly at
first until a normocytic normochromic state was reached at
puberty and then more slowly until just before adulthood
when both plateaued.

A direct, linear correlation between

erythrocytic ALAD activity and blood reticulocyte percent
was found with a P value of less than 0.001.

These findings

should be carefully considered when using the rat as a model
for lead poisoning and, possibly, for other disorders of
heme synthesis.
When establishing reference values for the ALAD activity of normal, healthy, nonmedicated adult male and female
volunteers a highly significant difference was found between
the mean male ALAD activity of 44.2 mU/ml RBC and the mean
female ALAD activity of 48.2 mU/ml
less than 0.01.

P~C,

with a P value of

While the biological significance of this
148
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difference is uncertain at the present time since it has
been suggested that there is excess enzyme present in the
body, it should, nonetheless, be considered when establishing reference values for the erythrocytic ALAD assay.
It was the major objective of this work to determine,
in a dose-response fashion, the in vitro effects of Na+ ,
2
2
Mg + 2 , Al+ 3 , Mn+ , Cu + , Ag + , Zn + 2 , Cd+ 2 , Hg + 2 , Ga + 3 , I n + 3 ,
2
· ALAD an d on an
Sn + , and Sn+4 on norma 1 eryt h rocytLc
enzyme 50% inhibited by Pb+ 2 while at the same time examining the ability of a maximally stimulatory concentration of
.
.
d'Lscovere d on screenLng,
.
zn +2 , to
an actLvator
meta 1 Lon
prevent or reverse the effects of these metal ions.

As a

result of this work several important conclusions were
reached concerning the physical and chemical properties
associated with the ability of a metal ion to activate or
inhibit human erythrocytic ALAD.

All hard Lewis acids,

regardless of valence electronic configuration or oxidation
state, were found to have no significant effect on ALAD
activity except at very high concentrations.

Divalent zinc

and cadmium, borderline or soft Lewis acids having characteristic coordination numbers that give them the electronic
configuration of noble gases, were the only ions found to
activate erythrocytic ALAD and to prevent or reverse the
. duce d Ln
. h'b'
.
Pb + 2 -Ln
L LtLon
o f th e enzyme. zn + 2 cou ld prevent
or reverse the in vitro inhibition of ALAD by low concentrations of borderline Lewis acids having characteristic

150
coordination numbers that give them the electronic configuration of noble gases and a planar coordination geometry
that allow rr bonding through donating electrons into an
empty d orbital of a ligand. Zn+2 could not, however, prevent or reverse the inhibition of ALAD induced by low concentrations of soft Lewis acids having characteristic coordination numbers that do not give them the electronic configuration of noble gases and a planar coordination geometry
that allows rr bonding through accepting electrons from a
ligand into an empty £ orbital.

On preincubation with the

enzyme for as little as one-half hour the soft Lewis acid
Cd+2 only inhibited ALAD but the borderline Lewis acid zn+2
could still activate ALAD after preincubation with the
enzyme for as long as four hours.

These results suggest

that the metal ions are affecting the activity of ALAD by an
interaction with the sulfhydryl groups of enzyme. These
results also suggest that zn+ 2 is possibly the in vivo metal
ion activator of the metal-enzyme complex ALAD but do not
rule out the possibil:ity that l.• t l.·s cu+ and not zn+ 2 that is
the activator of ALAD. It is proposed that Zn+2 be used as
a prophylactic agent or therapeutic adjunct to prevent or
reverse the Pb+ 2 -induced inhibition of ALAD and the resulting anemia and possibly toxic accumlation of the substrate
ALA.
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Stop reaction by the addition of:

4,

2

Head the optical density at 555 nm using a 1.0 em light path cuvet in a colorimeter
set to 10o;t transmission with a reagent blank. in which water is substituted for
blood.

6,

l'IC:UJW

WittJdraw a 2,0 ml aliquot of the supernatant fluld, add 2.0 ml of modified Ehrlich's
reagent (2 N with respect to PCA) and allow 15 min for color development.

5.

mix and let stand for 5 min and then centrifuge at 600 x g for 10 min at room temp.

l} 1.0 ml lO,i TCA containing 0.02 M N-ethylmalelmide
2) 0,05 ml saturated cupric sulfate solution

Add 1.0 ml of 0.01 M ALA·IICl in 0.25 M dlbaslc sodium phosphate/citric acid
buffer at pll 6.7 also warmed to 37 °C, gently vortex, cover tube ami incubate
for 1 hr at 37 °C.

up to

3.

•c

Add 100 mlcroltters of whole blood to 1.5 ml of aqueous 0.2~ Triton X-100 in a
16 x 125 mm test-tube, gently vortex and wann to 3'7 °C for 5 min.

(t1eparlnized blood ~llamples can also be stored in a refrigerator at 4
24 hra without loss of ALAD activity)

Collect blood Into heparinized tube and immediately place tube in an lee-bath.
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1.0 ml 10% TCA containing 0.02 M N-ethylmaleimide
0.05 ml saturated cupric sulfate solution

F'IGUHE 4

Read the optical density at 555 nm using a 1.0 em light path cuvet in a colorimeter
set to 1 OOZ t ransml ss ion with a reagent blank in which water is subst 1tuted for

7.

blooJ.

Withdraw a 2.0 ml aliquot of the supernatant fluid, add 2.0 ml of modified Ehrlich's
reagent (2 N with respect to PCA) and allow 15 min for color development.

mix and let stand for 5 min and then centrifuge at 600 x g for 10 min at room temp.

.!)

1)

Stop reaction by the addition of:

Immediately add 1.0 ml of 0.01 M ALA·IICl in 0.25 M dibasic sodium phosphate/citric
acid buffer at pH 6.7 also warmed to 37 C, gently vortex, cover tube and incubate
for I hr at 37 C. (Final incubation volume of 2.6 ml.)

lnun...,diately add 100 microliters of aqueous 0.2% Tri.ton X-100 and/or 100 microliter:; of aqueous 0.2% Triton X-100 inhibitor solution and/or 100 microliters of
aqueou:; 0.2% Triton X-100 activator solution.

Add 100 microli.ter:; of whole blood to 1.3 ml of aqueous 0.2% Triton X-100 in a
lh x 125 ~n test-tube, gently vortex and warm to 37 C for 5 min.

(Heparinized blood samples can also be stored in a refrigerator at 4 C up to
24 hrs without lo:;s of AI.AD activlty.)

Collect blood into heparinized tul>e and immediately place tube in an ice-bath.
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The variation of various hematologic indices,
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including hemoglobin, hematocrit, mean corpuscular volume
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(MCV), and mean corpuscular hemoglobin (MCH), with the age
of the male albino rat.
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Each point represents the average

of results obtained from three animals.

~I

<t

I
I
I

0

I
I

1Ct:

z

ffi

...J

<t

UJ

...J

<t
::E

en

!

I
:r·
ul
~·
I

0

CD

i
i

0

1

\ . .. fI

I

0

!

I

9
(J')

1

1'(J')

r

\.I

0

·~.

•

9
I

I

i

<t
::E

\j

z

""<l

I
I

·'
I
I

\0
\
\
\

...J

,.......

I
I

I

..I

I

<t

[\..

Ii · · . .··..
<i

i
i

u...

0

UJ

·~..\.

(.!)

<t

\.
\
~
\

0

C\J

~

"'\

Q
~

c--- -0

<t

0

I \

..

\
\
\

<D

(% wO) N 1901901113H

If)

~
,..~

;::J
_,
'-'

H
~

163
162

..
.··

'•

FIGURE 6.

..

The variation of blood reticulocyte percent with

the age of the male albino rat.

Each point represents the
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FIGURE 7.

The variation of erythrocytic ALAD activity with

the age of the male albino rat.

Each point represents the

average of results obtained from three animals.
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The relationship between erythrocytic ALAD

activity and blood reticulocyte percent.

Each point repreLU

sents the determination of ALAD activity and reticulocyte
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percent in each of 27 individual male albino rats studied.
The correlation coefficient (r) was determined to be 0.967
with a P value of less than 0.001.
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EFFECT OF Cu......
ON NORMAL ADULT
HUMAN BLOOD ALAD ACTIVITY
in vitro
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FIGURE 9.

The concentration curve for the effect of Cu+ 2
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• 1.5 x 10·5 M CUPRIC ACETATE
90 (0.95 JICJ/ml Cu l

on normal adult human erythrocytic ALAD activity in vitro.
Each point represents the mean

±

= t S.E.M. OF 4 EXPERIMENTS

S.E.M. of results obtained

for 4 individuals.
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EFFECT OF Pb••.zn-.cd++, AND Hg++ON NORMAL
ADULT HUMAN BLOOD ALAD ACTIVITY
in vitro
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FIGURE 10. The effect of various concentrations of Pb+ 2 ,
zn+ 2 , Cd+ 2 , and Hg+Z on normal adult human erythrocytic ALAD
activity in vitro.

T·"

)···t
,>t
I ·. i'

... ·!_........... ... ... "·.·.
-·,i
.

Each point represents the mean ± S.E.M.

·,

of results obtained for 4 individuals.

·,.

'.~

..
\

0.001

0.01

0.1.
I
4
x 10- M DIVALENT CATION

\

\

'I
\

zn••
\

'!

172

173

...
'•

EFFECT CF ZlNC ACETATE ON LEAD ACETATE-INDUCED INHIBITICN
CF NCRMAL Alll. T HUMAN BLOOD ALAD ACTIVITY in Yilr:Q
(lead and zinc added to hemdysote immediately pior to 1hour ino;bation with ALA at 37 C)
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FIGURE 11.

The effect of zinc acetate on lead acetate-

induced inhibition of normal adult human erythrocytic ALAD
in vitro.

Lead and zinc were added to the hemolysates
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The effect of zinc acetate on copper acetate-
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induced inhibition of normal adult human erythrocytic ALAD
in vitro.

Copper and zinc were added to the hemolysates

immediately prior to the 1.0 hour incubation with ALA at
NO Zn••

37°C.
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obtained for 6 individuals.
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EFFECT OF Zn.. ON IDso Pb++ AND ON ID50
INJUCED INHIBITION OF NORMAL ADULT
HUMAN BLOOD ALAD ACTIVITY in vitro
~
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Each point represents the mean
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The concentration curves for the effect of zn+Z
of rn 50 Pb+Z_ and on rn
Cu+ 2 -induced inhibition of
50
normal adult human erythrocytic ALAD activity in vitro.
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FIGURE 15. The effect of various concentrations of Pb+ 2 ,
Zn +2 , Cd+ 2 , and Hg+ 2 on normal, rn
Pb+ 2 inhibited, and
50
2
zn+ stimulated adult human erythrocytic ALAD
I

activity in vitro.
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